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1. INTRODUCTION {#tme12659-sec-0001}
===============

Haemorrhage is a potentially preventable cause of death after major trauma.[1](#tme12659-bib-0001){ref-type="ref"}, [2](#tme12659-bib-0002){ref-type="ref"}, [3](#tme12659-bib-0003){ref-type="ref"} Topical treatment is not always sufficient to control haemorrhage, since it is often non‐compressible.[3](#tme12659-bib-0003){ref-type="ref"}, [4](#tme12659-bib-0004){ref-type="ref"}, [5](#tme12659-bib-0005){ref-type="ref"} The lethal triad of acidosis, hypothermia and coagulopathy is related to haemorrhagic shock, especially when blood loss is treated with liberal crystalloid fluid replacement.[6](#tme12659-bib-0006){ref-type="ref"} In damage control resuscitation (DCR), blood products are preferred over crystalloids as fluid replacement, while a degree of hypotension is accepted until haemorrhage control has been achieved.[6](#tme12659-bib-0006){ref-type="ref"}, [7](#tme12659-bib-0007){ref-type="ref"}, [8](#tme12659-bib-0008){ref-type="ref"}, [9](#tme12659-bib-0009){ref-type="ref"}, [10](#tme12659-bib-0010){ref-type="ref"}, [11](#tme12659-bib-0011){ref-type="ref"}

Through transfusion of red blood cells (RBC), the infusion of large volumes of crystalloids may be avoided, as RBC provide a more effective volume expansion. Haemostasis and thrombosis are promoted[12](#tme12659-bib-0012){ref-type="ref"} and oxygen carrying capacity restored.[13](#tme12659-bib-0013){ref-type="ref"}

In an effort to decrease mortality through haemorrhage after major trauma, prehospital transfusion of red blood cells (PHTRBC) is increasingly performed. Military medical teams have been transfusing blood products prior to arrival at a surgical unit for years.[14](#tme12659-bib-0014){ref-type="ref"}, [15](#tme12659-bib-0015){ref-type="ref"} This may partially explain survival differences between civilian casualties who require massive transfusion (60%) and military casualties (93%).[16](#tme12659-bib-0016){ref-type="ref"} More recently, civilian emergency medical services (EMS) have also started to carry blood to the scene and transfuse their patients in the prehospital setting.[17](#tme12659-bib-0017){ref-type="ref"}, [18](#tme12659-bib-0018){ref-type="ref"}

In part 1 of this series, we described the availability and frequency of PHTRBC around the world, and demonstrated that varying transfusion criteria are being used.[19](#tme12659-bib-0019){ref-type="ref"} However, to date, little is known concerning the effects on patient outcomes. We have therefore conducted a systematic review with the aim to evaluate the effect of PHTRBC in patients treated by EMS on multiple outcomes including mortality, haemodynamic parameters, and the need for further in‐hospital transfusions.

2. METHODS {#tme12659-sec-0002}
==========

The review was registered at Prospero (website: <https://www.crd.york.ac.uk/prospero>, identification number: CRD42018084658). This systematic review was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines.[20](#tme12659-bib-0020){ref-type="ref"}

2.1. *Information sources, search strategy and study selection* {#tme12659-sec-0003}
---------------------------------------------------------------

PubMed and Web of Science were searched through January 2019. The search strategy and the process of selection of studies were described previously.[19](#tme12659-bib-0019){ref-type="ref"} For the purpose of this systematic review, only the manuscripts reporting outcome measures after PHTRBC (data on the hemodynamic state, coagulopathy, 24 hours RBC transfusion requirement, length of stay in hospital/intensive care unit \[ICU\], mortality, or occurrence of complications) were included. For a comprehensive overview of studies reporting outcomes after PHTRBC, controlled studies as well as observational studies were considered for this systematic review.

2.2. *Data extraction* {#tme12659-sec-0004}
----------------------

A standardised data extraction sheet was developed, and after testing this on the first 20 articles, it was refined. The setting and type of transport the EMS used (civilian or military, scene or interfacility) and patient characteristics were extracted. Data regarding the effects of prehospital transfusion were collected, including haemodynamic data, coagulopathy, 24 hours RBC transfusion requirement, length of stay in hospital/ICU, mortality and occurrence of complications. Descriptions of problems that arose during PHTRBC are summarised in the text.

Bias was assessed using the Newcastle‐Ottawa Scale.[21](#tme12659-bib-0021){ref-type="ref"}

2.3. *Data synthesis* {#tme12659-sec-0005}
---------------------

A priori, we had planned a random‐effects meta‐analysis of the available evidence. However, no controlled studies were identified, and the observational studies carry a risk of residual confounding even if matching or regression‐based techniques were used to control for confounding. Moreover, a high heterogeneity among the studies precluded meaningful pooling of data: Civilian and military studies are not comparable due to fundamental differences in patients, mechanisms of injury and medical facilities. Also within these two groups, differences between patient populations and patient selection, differences between healthcare systems and EMS systems (eg, logistics, staff, equipment, treatment options, response and transport times to definitive care), differences in the type of blood products used (RBC only or a combination of blood products), differences in transfusion criteria, as well as differences in outcome measures are too great to allow a meaningful combined analysis. A meta‐analysis was therefore not performed.

3. RESULTS {#tme12659-sec-0006}
==========

3.1. *Selection of articles* {#tme12659-sec-0007}
----------------------------

The search in PubMed and Web of Science yielded 2172 hits after removal of duplicates. In our scoping review, 71 articles were included.[19](#tme12659-bib-0019){ref-type="ref"} In total, 55 of these studies reported one or more outcome measure, and were included in this review (Figure [1](#tme12659-fig-0001){ref-type="fig"}).

![PRISMA flow diagram](TME-30-106-g001){#tme12659-fig-0001}

Forty‐one of these studies discussed PHTRBC in civilian medical services, 14 of which allowed comparisons of PHTRBC with a control population. Notably, four articles primarily dealt with a different study topic, but were included as they additionally provided valuable information regarding PHTRBC[22](#tme12659-bib-0022){ref-type="ref"}, [23](#tme12659-bib-0023){ref-type="ref"}, [24](#tme12659-bib-0024){ref-type="ref"}, [25](#tme12659-bib-0025){ref-type="ref"} (Table [1](#tme12659-tbl-0001){ref-type="table"}).

###### 

Overview of studies

<table><thead><tr class="header"><th style="text-align: left;">First author (y)</th><th style="text-align: left;">Region</th><th style="text-align: left;">Study period</th><th style="text-align: left;">Primary goal</th><th style="text-align: left;">Study group</th><th style="text-align: left;">Control group</th><th style="text-align: left;">Control for confounding</th><th style="text-align: left;">patients transfused (<em>n</em>)<a href="#tme12659-note-0003" data-ref-type="fn">a</a></th><th style="text-align: left;">Type of transport (%trauma)</th><th style="text-align: left;">Mechanism of injury</th><th style="text-align: left;">ISS</th></tr></thead><tbody><tr class="odd"><td style="text-align: left;"><strong>Civilian services</strong></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="even"><td style="text-align: left;">Prospective comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="odd"><td style="text-align: left;">Henriksen H (2016)<a href="#tme12659-bib-0026" data-ref-type="ref">26</a></td><td style="text-align: left;">Texas USA</td><td style="text-align: left;">2012‐2013</td><td style="text-align: left;">To investigate the association between PHTRBC and PHT‐plasma and hemostatic function</td><td style="text-align: left;">Receivers of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">Receivers of in‐hospital transfusion</td><td style="text-align: left;">Adjusted data</td><td style="text-align: left;">75<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHT: Blunt: 55% Penetrating: 45%</p><p>Control: Blunt: 75% Penetrating: 25% <em>P</em> = .002</p></td><td style="text-align: left;"><p>PHT: 29 (17‐41)</p><p>Control:</p><p>26 (17‐34) <em>P</em> = .106</p></td></tr><tr class="even"><td style="text-align: left;">Holcomb J (2017)<a href="#tme12659-bib-0027" data-ref-type="ref">27</a></td><td style="text-align: left;">USA (9 trauma centers)</td><td style="text-align: left;">2015</td><td style="text-align: left;">To study the effect of PHTRBC and/or PHT‐plasma on in‐hospital mortality</td><td style="text-align: left;">Severely injured receivers of PHTRBC and/or plasma</td><td style="text-align: left;">No prehospital blood products</td><td style="text-align: left;">Propensity score</td><td style="text-align: left;">142<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHT: Blunt: 79.1% Penetrating: 20.9%</p><p>Matched control: Blunt: 72.7% Penetrating: 27.3%</p></td><td style="text-align: left;"><p>PHT: 24 (10‐34)</p><p>Control:</p><p>22 (10‐34)</p></td></tr><tr class="odd"><td style="text-align: left;">Retrospective comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="even"><td style="text-align: left;">Brown JB‐a (2015)<a href="#tme12659-bib-0028" data-ref-type="ref">28</a></td><td style="text-align: left;">USA (9 institutions)</td><td style="text-align: left;">2003‐2010</td><td style="text-align: left;">To characterise the association of pre‐trauma center RBC with mortality and TIC in severely injured patients with blunt trauma</td><td style="text-align: left;">Receivers of pre‐trauma center RBC</td><td style="text-align: left;">No prehospital transfusion</td><td style="text-align: left;">Propensity score</td><td style="text-align: left;">50</td><td style="text-align: left;">Scene + interfacility (100%)</td><td style="text-align: left;"><p>Blunt: 100%</p><p>Penetrating: 0%</p><p>(per exclusion)</p></td><td style="text-align: left;"><p>PHTRBC:</p><p>34 (18‐43)</p><p>Control: 30 (23‐43) <em>P</em> = .81</p></td></tr><tr class="odd"><td style="text-align: left;">Brown JB‐b (2015)<a href="#tme12659-bib-0029" data-ref-type="ref">29</a></td><td style="text-align: left;">Pennsylvania USA</td><td style="text-align: left;">2007‐2012</td><td style="text-align: left;">To evaluate the association of pre‐trauma center RBC with outcomes</td><td style="text-align: left;">Receivers of pre‐trauma center RBC</td><td style="text-align: left;">No prehospital transfusion</td><td style="text-align: left;">Propensity score</td><td style="text-align: left;">240 matched (71 scene)</td><td style="text-align: left;">Scene+ interfacility (100%)</td><td style="text-align: left;"><p>PHTRBC: Blunt: 191(80%) Penetrating: 49(20%)</p><p>Matched Controls: Blunt: 395(82%) Penetrating: 85(18%)</p></td><td style="text-align: left;"><p>PHTRBC: 18 (10‐29)</p><p>Matched Control: 17 (9‐27) <em>P</em> = .05</p></td></tr><tr class="even"><td style="text-align: left;">Griggs JE (2018)<a href="#tme12659-bib-0030" data-ref-type="ref">30</a></td><td style="text-align: left;">Kent Surrey &amp; Sussex UK</td><td style="text-align: left;">2010‐2015</td><td style="text-align: left;">To compare mortality for patients with suspected traumatic haemorrhage receiving PHTRBC compared to crystalloid</td><td style="text-align: left;">Code Red patients receiving PHTRBC</td><td style="text-align: left;">Code Red patients receiving crystalloids</td><td style="text-align: left;">Adjusted data</td><td style="text-align: left;">92</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHTRBC: Blunt: 95% Penetrating: 5% MVC 68% Fall 9%</p><p>Control: Blunt: 99% Penetrating: 1% MVC: 58% Fall: 9%</p></td><td style="text-align: left;"><p>Mean (SD) PHTRBC:32 (12)</p><p>Control: 21 (14) <em>P</em> = .67</p></td></tr><tr class="odd"><td style="text-align: left;">Holcomb JB‐b (2015)<a href="#tme12659-bib-0018" data-ref-type="ref">18</a></td><td style="text-align: left;">Texas USA</td><td style="text-align: left;">2011‐2013</td><td style="text-align: left;">To evaluate effect of PHTRBC and/or PHT‐plasma on survival and blood product use</td><td style="text-align: left;">Receivers of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">Receivers of in‐hospital transfusion</td><td style="text-align: left;">adjusted data</td><td style="text-align: left;">137<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHT: Blunt: 77% Penetrating: 23%</p><p>Control: Blunt 83% Penetrating 17% <em>P</em> = .447</p></td><td style="text-align: left;"><p>PHT: 22 (12‐29)</p><p>Control: 22 (11‐33) <em>P</em> = .998</p></td></tr><tr class="even"><td style="text-align: left;">Kim BD (2012)<a href="#tme12659-bib-0022" data-ref-type="ref">22</a></td><td style="text-align: left;">Minnesota USA</td><td style="text-align: left;">2009‐2011</td><td style="text-align: left;">The analyse the effect of PHT‐plasma on coagulopathy</td><td style="text-align: left;">Receivers of PHT‐plasma + PHTRBC</td><td style="text-align: left;">Receivers of PHTRBC only</td><td style="text-align: left;">no</td><td style="text-align: left;">59 (of whom 50 RBC only)</td><td style="text-align: left;">Scene+ interfacility (100%)</td><td style="text-align: left;"><p>Plasma: Blunt: 67% Penetrating: 33%</p><p>PHTRBC only: Blunt: 82% Penetrating 18% <em>P</em> = .317</p></td><td style="text-align: left;"><p>Plasma: 27</p><p>PHTRBC: 23 <em>P</em> = .918</p></td></tr><tr class="odd"><td style="text-align: left;">Miller B (2016)<a href="#tme12659-bib-0031" data-ref-type="ref">31</a></td><td style="text-align: left;">Tennessee USA</td><td style="text-align: left;">2007‐2013</td><td style="text-align: left;">To examine the impact of PHTRBC on mortality</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">No prehospital transfusion</td><td style="text-align: left;">Propensity score</td><td style="text-align: left;">231 (195 matched)</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHTRBC: Blunt: 78% Penetrating: 22%</p><p>Matched control: Blunt: 90% Penetrating: 10% <em>P</em> &lt; .001</p></td><td style="text-align: left;"><p>PHTRBC: 34 (22‐43)</p><p>Matched control: 32 (22‐43)</p><p><em>P</em> = .903</p></td></tr><tr class="even"><td style="text-align: left;">Parker ME (2017)<a href="#tme12659-bib-0032" data-ref-type="ref">32</a></td><td style="text-align: left;">Minnesota USA</td><td style="text-align: left;">2010‐2014</td><td style="text-align: left;">To examine PHT of plasma and/or RBC on outcomes in exsanguinating GI bleeding</td><td style="text-align: left;">Receivers of PHTRBC and/or PHT‐plasma with acute GI bleeding</td><td style="text-align: left;">Vs GI‐bleed patients without transfusion</td><td style="text-align: left;">No</td><td style="text-align: left;">112<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Interfacility (0%)</td><td style="text-align: left;">n/a</td><td style="text-align: left;">n/a</td></tr><tr class="odd"><td style="text-align: left;">Peters J (2017)<a href="#tme12659-bib-0033" data-ref-type="ref">33</a></td><td style="text-align: left;">Nijmegen Rotterdam The Netherlands</td><td style="text-align: left;">2007‐2015</td><td style="text-align: left;">To establish the efficacy and safety of the PHTRBC by HEMS</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">Receivers of crystalloids only</td><td style="text-align: left;">Matched</td><td style="text-align: left;">73 (50 matched)</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHTRBC: Blunt: 93% Penetrating: 7% MVC 70% Fall from height 10%</p><p>Matched control: Blunt: 94% Penetrating: 6% MVC 68% Fall from height 12%</p></td><td style="text-align: left;"><p>PHTRBC: 34 (9‐75)</p><p>Control:</p><p>35 (18‐75) <em>P</em> = .242</p></td></tr><tr class="even"><td style="text-align: left;">Price DD (1999)<a href="#tme12659-bib-0034" data-ref-type="ref">34</a></td><td style="text-align: left;">Oregon USA</td><td style="text-align: left;">1989‐1995</td><td style="text-align: left;">To evaluate the efficacy of early blood transfusion</td><td style="text-align: left;">Receivers of PHTRBC during air transport</td><td style="text-align: left;">Receivers of crystalloids in ground transport</td><td style="text-align: left;">Matched</td><td style="text-align: left;">84</td><td style="text-align: left;">n/d (100%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Rehn M (2018)<a href="#tme12659-bib-0035" data-ref-type="ref">35</a></td><td style="text-align: left;">London UK</td><td style="text-align: left;">2009‐2015</td><td style="text-align: left;">To investigate the effect of PHTRBC on overall blood product use</td><td style="text-align: left;">“Code Red” patients after implementation of PHTRBC</td><td style="text-align: left;">“Code Red” patients before implementation of PHTRBC</td><td style="text-align: left;">Adjusted data</td><td style="text-align: left;">128</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHTRBC: Blunt: 64.8% Penetrating: 35.2% MVC: 42.2% Falls: 11.7%</p><p>Control: Blunt: 68.6% Penetrating: 31.4% MVC: 42.3% Falls: 12.4% Other blunt: 13.9%</p></td><td style="text-align: left;"><p>PHTRBC: 29 (25‐43)</p><p>Control:</p><p>27 (19‐41)</p></td></tr><tr class="even"><td style="text-align: left;">Rehn M (2019)<a href="#tme12659-bib-0036" data-ref-type="ref">36</a></td><td style="text-align: left;">London UK</td><td style="text-align: left;">2009‐2015</td><td style="text-align: left;">To investigate the effect of PHTRBC on mortality</td><td style="text-align: left;">“Code Red” patients after implementation of PHTRBC</td><td style="text-align: left;">“Code Red” patients before implementation of PHTRBC</td><td style="text-align: left;">Adjusted data</td><td style="text-align: left;">239</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>PHTRBC: Blunt: 146 (61%) Penetrating 93 (39%)</p><p>Control: Blunt: 189 (63%) Penetrating: 111 (37%)</p></td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Sumida MP (2000)<a href="#tme12659-bib-0037" data-ref-type="ref">37</a></td><td style="text-align: left;">Tennessee Connecticut USA</td><td style="text-align: left;">1995‐1996</td><td style="text-align: left;">To analyse the effect of PHTRBC on physiologic parameters and outcome</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">Receivers of crystalloids only</td><td style="text-align: left;">no</td><td style="text-align: left;">17</td><td style="text-align: left;">Scene+ interfacility (100%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;"><p>PHTRBC 28</p><p>Control: 27.8</p><p><em>P</em> = .957</p></td></tr><tr class="even"><td style="text-align: left;">Prospective not‐comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="odd"><td style="text-align: left;">Chang R (2018)<a href="#tme12659-bib-0025" data-ref-type="ref">25</a></td><td style="text-align: left;">USA (9 trauma centers)</td><td style="text-align: left;">2015</td><td style="text-align: left;">To describe the phenotype and laboratory coagulation abnormalities of clinically evident coagulopathic bleeding (CC) after trauma</td><td style="text-align: left;">Highest‐risk trauma patients, CC+</td><td style="text-align: left;">CC‐</td><td style="text-align: left;">Adjusted data</td><td style="text-align: left;">PHTRBC in CC+ vs CC‐ 18 (44%) vs 82 (8%) <em>P</em> &lt; .001</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>Overall: CC+ vs CC‐:</p><p>Blunt: 28 (68%) vs 792 (81%) Penetrating: 12 (30%) vs 165 (17%) Both: 1 (2%) vs 21 (2%)</p><p>Injury type <em>P</em> = .09</p></td><td style="text-align: left;"><p>CC+:32 (25‐41)</p><p>CC‐: 17 (8‐27)</p><p><em>P</em> &lt; .001</p></td></tr><tr class="even"><td style="text-align: left;">Reed M (2017)<a href="#tme12659-bib-0024" data-ref-type="ref">24</a></td><td style="text-align: left;">Scotland</td><td style="text-align: left;">2013‐2015</td><td style="text-align: left;">To evaluate the prehospital activation of Code Red</td><td style="text-align: left;">Patients for whom a pre‐hospital Code Red was activated</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">16</td><td style="text-align: left;">n/d (100%)</td><td style="text-align: left;">Overall: Blunt: 44 (83%) Penetrating: 9 (17%)</td><td style="text-align: left;"><p>Overall:</p><p>24 (14‐37)</p></td></tr><tr class="odd"><td style="text-align: left;">Sherren PB (2013)<a href="#tme12659-bib-0038" data-ref-type="ref">38</a></td><td style="text-align: left;">Greater Sydney Area Australia</td><td style="text-align: left;">n/s (5 y)</td><td style="text-align: left;">To describe PHTRBC</td><td style="text-align: left;">Missions involving PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">147</td><td style="text-align: left;">n/d (100%)</td><td style="text-align: left;">Blunt: 93.9% Penetrating: 6.1% MVC: 79 Fall from height: 3.4% Other: 11.6%</td><td style="text-align: left;"><p>RTS: 5.967</p><p>(4.083‐6.904)</p></td></tr><tr class="even"><td style="text-align: left;">Weaver AE (2012)<a href="#tme12659-bib-0039" data-ref-type="ref">39</a></td><td style="text-align: left;">London UK</td><td style="text-align: left;">2012</td><td style="text-align: left;">To examine the impact of on‐scene PHTRBC for seriously injured patients</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">50</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Retrospective not‐comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="even"><td style="text-align: left;">Berns KS (1998)<a href="#tme12659-bib-0040" data-ref-type="ref">40</a></td><td style="text-align: left;">Minnesota USA</td><td style="text-align: left;">1993‐1996</td><td style="text-align: left;">To document the development of protocols for and to review the experience with PHTRBC</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">94</td><td style="text-align: left;">scene+ interfacility (48%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Bodnar D‐b (2014)<a href="#tme12659-bib-0041" data-ref-type="ref">41</a></td><td style="text-align: left;">Greater Brisbane Australia</td><td style="text-align: left;">2011‐2012</td><td style="text-align: left;">To describe the characteristics, clinical interventions and the outcomes of PHTRBC patients</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">71</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>Blunt: 73.2%</p><p>Penetrating: 26.8%</p><p>MVC 67%</p></td><td style="text-align: left;">Mean (SD) 32.1 (18.2)</td></tr><tr class="even"><td style="text-align: left;">Dalton AM (1993)<a href="#tme12659-bib-0042" data-ref-type="ref">42</a></td><td style="text-align: left;">Oregon Washington USA</td><td style="text-align: left;">1985‐1992</td><td style="text-align: left;">To show that PHTRBC is safe and practical</td><td style="text-align: left;">Receivers of PHTRBC with MAST</td><td style="text-align: left;">Receivers of PHTRBC without MAST</td><td style="text-align: left;">n/a</td><td style="text-align: left;">112</td><td style="text-align: left;">n/d (100%)</td><td style="text-align: left;"><p>Overall: Blunt: 86%</p><p>Penetrating: 14%</p><p>MVC: 72%</p></td><td style="text-align: left;"><p>Mean: MAST: 33</p><p>non‐MAST: 31</p></td></tr><tr class="odd"><td style="text-align: left;">Fahy AS (2017)<a href="#tme12659-bib-0043" data-ref-type="ref">43</a></td><td style="text-align: left;">Minnesota USA</td><td style="text-align: left;">2002‐2014</td><td style="text-align: left;">To report our experience with a prehospital transfusion protocol in pediatric patients</td><td style="text-align: left;">Pediatric trauma patients receiving PHTRBC and/or ‐plasma</td><td style="text-align: left;">Pediatric non‐trauma patients receiving PHTRBC and/or ‐plasma</td><td style="text-align: left;">n/a</td><td style="text-align: left;">28<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">scene+ interfacility (57%)</td><td style="text-align: left;"><p>Blunt: 88%</p><p>Penetrating: 12%</p><p>MVC: 63%</p><p>Gunshot wounds: 13%</p></td><td style="text-align: left;">24 (range 9‐66)</td></tr><tr class="even"><td style="text-align: left;">Heschl S (2018)<a href="#tme12659-bib-0044" data-ref-type="ref">44</a></td><td style="text-align: left;">Victoria Australia</td><td style="text-align: left;">2011‐2015</td><td style="text-align: left;">To describe the characteristics of PHTRBC</td><td style="text-align: left;">All cases where approval for PHTRBC was sought by paramedics</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">142</td><td style="text-align: left;">Scene (96%)</td><td style="text-align: left;"><p>Blunt/penetrating: n/d</p><p>MVC: 88%</p><p>Crush/fall/other: 11.8%</p></td><td style="text-align: left;"><p>mean (SD):</p><p>36.5 (15.8)</p></td></tr><tr class="odd"><td style="text-align: left;">Higgins GL (2012)<a href="#tme12659-bib-0045" data-ref-type="ref">45</a></td><td style="text-align: left;">Maine USA</td><td style="text-align: left;">2007‐2008</td><td style="text-align: left;">To describe PHTRBC with respect to safety and efficacy and improvement in condition</td><td style="text-align: left;">receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">45</td><td style="text-align: left;">scene+ interfacility (71%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Hooper N (2017)<a href="#tme12659-bib-0046" data-ref-type="ref">46</a></td><td style="text-align: left;">Southwest UK</td><td style="text-align: left;">2015‐2016</td><td style="text-align: left;">To describe experience with PHTRBC</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">62</td><td style="text-align: left;">n/d (84%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Krook C (2018)<a href="#tme12659-bib-0047" data-ref-type="ref">47</a></td><td style="text-align: left;">Western Canada</td><td style="text-align: left;">2013‐2017</td><td style="text-align: left;">To describe the implementation and stewardship of a prehospital blood transfusion program</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">274</td><td style="text-align: left;">scene+ interfacility (74%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Krugh D (1994)<a href="#tme12659-bib-0048" data-ref-type="ref">48</a></td><td style="text-align: left;">Ohio USA</td><td style="text-align: left;">1991‐1993</td><td style="text-align: left;">To describe and review the implementation of an off‐site blood product storage program</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">8</td><td style="text-align: left;">n/d (50%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Lyon R (2017)<a href="#tme12659-bib-0049" data-ref-type="ref">49</a></td><td style="text-align: left;">Kent Surrey &amp; Sussex UK</td><td style="text-align: left;">2013‐2014</td><td style="text-align: left;">To describe the characteristics of receivers of PHTRBC and evaluate their subsequent in‐hospital needs</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">147</td><td style="text-align: left;">scene (97%)</td><td style="text-align: left;"><p>Blunt: 128 (87%) Penetrating: 14 (10%) MVC: 103 (73%)</p><p>Fall from height: 17 (11.6%)</p></td><td style="text-align: left;">33 (SD 13.4)</td></tr><tr class="even"><td style="text-align: left;">Maher P (2017)<a href="#tme12659-bib-0050" data-ref-type="ref">50</a></td><td style="text-align: left;">Washington, USA</td><td style="text-align: left;">2015</td><td style="text-align: left;">To describe the development of a HEMS transfusion program</td><td style="text-align: left;">Receivers of PHTRBC or ‐plasma</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;"><p>RBC 13</p><p>FFP 3</p></td><td style="text-align: left;">scene+ interfacility (85%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Mena‐Munoz J (2016)<a href="#tme12659-bib-0051" data-ref-type="ref">51</a></td><td style="text-align: left;">Pennsylvania Ohio Maryland USA</td><td style="text-align: left;">2003‐2012</td><td style="text-align: left;">To characterise receivers of out of hospital transfusion of blood products (mostly RBC and/or plasma) during critical care transport</td><td style="text-align: left;">Receivers of out of hospital blood products</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">1440<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Scene + interfacility (19%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Mix FM (2018)<a href="#tme12659-bib-0052" data-ref-type="ref">52</a></td><td style="text-align: left;">Minnesota, USA</td><td style="text-align: left;">2011‐2015</td><td style="text-align: left;">To determine whether opportunities for blood product administration by ground ALS ambulances exist</td><td style="text-align: left;">Adult trauma patients with potential need for prehospital blood administration</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">28</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;"><p>Blunt: 26 (93%)</p><p>Penetrating: 2 (7%)</p></td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Potter D (2015)<a href="#tme12659-bib-0053" data-ref-type="ref">53</a></td><td style="text-align: left;">Minnesota USA</td><td style="text-align: left;">2003‐2012</td><td style="text-align: left;">To summarize our initial experience with PHTRBC and PHT‐plasma in pediatric trauma patients</td><td style="text-align: left;">Receivers (&lt;18 y) of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">16<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Scene + interfacility (100%)</td><td style="text-align: left;"><p>Blunt: 87.5%</p><p>Penetrating: 12.5%</p></td><td style="text-align: left;">Mean 30 (range 9‐66)</td></tr><tr class="even"><td style="text-align: left;">Raitt JE (2018)<a href="#tme12659-bib-0054" data-ref-type="ref">54</a></td><td style="text-align: left;">Thames Valley UK</td><td style="text-align: left;">2014‐2016</td><td style="text-align: left;">To review the appropriateness of PHTRBC and to identify outcomes</td><td style="text-align: left;">receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">n/a</td><td style="text-align: left;">Scene (95%)</td><td style="text-align: left;">Blunt: 53 (84%) Penetrating: 7 (11%) MVC 42 (67%) Fall 8 (13%)</td><td style="text-align: left;">ISS 34 (21‐43)</td></tr><tr class="odd"><td style="text-align: left;">Sunde GA (2015)<a href="#tme12659-bib-0055" data-ref-type="ref">55</a></td><td style="text-align: left;">Bergen Norway</td><td style="text-align: left;">2014</td><td style="text-align: left;">To describe our preliminary results after implementing PHTRBC and PHT‐plasma</td><td style="text-align: left;">Receivers of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">4<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">scene (75%)</td><td style="text-align: left;"><p>Blunt: 67%</p><p>Penetrating: 33%</p></td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Thiels CA (2016)<a href="#tme12659-bib-0056" data-ref-type="ref">56</a></td><td style="text-align: left;">Minnesota USA</td><td style="text-align: left;">2002‐2014</td><td style="text-align: left;">To report our experience with prehospital blood product transfusion</td><td style="text-align: left;">Non‐trauma patients receiving PHTRBC and/or ‐plasma</td><td style="text-align: left;">Trauma patients receiving PHTRBC and/or ‐plasma</td><td style="text-align: left;">no</td><td style="text-align: left;">PHTRBC 654</td><td style="text-align: left;">Scene + interfacility (36%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Wheeler R (2013)<a href="#tme12659-bib-0023" data-ref-type="ref">23</a></td><td style="text-align: left;">New England USA</td><td style="text-align: left;">2005‐2009</td><td style="text-align: left;">To determine factors associated with hypothermia</td><td style="text-align: left;">trauma patients transported by HEMS, hypothermic on arrival</td><td style="text-align: left;">Non‐hypothermic trauma patients, transported by HEMS</td><td style="text-align: left;">n/a</td><td style="text-align: left;">30</td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">(Mean ± SD): Hypothermic: 26.07 ± 11.86 Non‐hypoth: 15.53 ± 11.39</td></tr><tr class="even"><td style="text-align: left;">Case reports</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="odd"><td style="text-align: left;">Garner AA (1999)<a href="#tme12659-bib-0057" data-ref-type="ref">57</a></td><td style="text-align: left;">Sydney Australia</td><td style="text-align: left;">1997</td><td style="text-align: left;">Case report</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;">n/a</td><td style="text-align: left;">1<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;">Blunt: 100%</td><td style="text-align: left;">43 (<em>n</em> = 1)</td></tr><tr class="even"><td style="text-align: left;">Lawton LD (2012)<a href="#tme12659-bib-0058" data-ref-type="ref">58</a></td><td style="text-align: left;">Queensland Australia</td><td style="text-align: left;">n/s</td><td style="text-align: left;">Case report</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;">n/a</td><td style="text-align: left;">1<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">Scene (100%)</td><td style="text-align: left;">Blunt: 100%</td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Macnab AJ (1996)<a href="#tme12659-bib-0059" data-ref-type="ref">59</a></td><td style="text-align: left;">British Columbia Canada</td><td style="text-align: left;">1996</td><td style="text-align: left;">Case report</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;">n/a</td><td style="text-align: left;">1</td><td style="text-align: left;">Interfacility (0%)</td><td style="text-align: left;">n/a</td><td style="text-align: left;">n/a</td></tr><tr class="even"><td style="text-align: left;">Description of protocol</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="odd"><td style="text-align: left;">Trembley AL (2016)<a href="#tme12659-bib-0060" data-ref-type="ref">60</a></td><td style="text-align: left;">Minnesota Wisconsin USA</td><td style="text-align: left;">2016</td><td style="text-align: left;">Description of implementation of protocol</td><td style="text-align: left;">n/a</td><td style="text-align: left;">n/a</td><td style="text-align: left;">n/a</td><td style="text-align: left;">n/d</td><td style="text-align: left;">Scene + interfacility (n/d)</td><td style="text-align: left;">n/d</td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Vartanian, L (2017)<a href="#tme12659-bib-0061" data-ref-type="ref">61</a></td><td style="text-align: left;">Texas, USA</td><td style="text-align: left;">2016</td><td style="text-align: left;">Description of implementation of protocol</td><td style="text-align: left;">Receivers of PHTRBC and/or ‐plasma</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">12</td><td style="text-align: left;">n/d (67%)</td><td style="text-align: left;"><p>Blunt: 7 (87%)</p><p>Penetrating: 1 (12%)</p><p>MVC: 5 (62%) Fall: 1 (8%)</p></td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;"><strong>Military services</strong></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="even"><td style="text-align: left;">Prospective comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="odd"><td style="text-align: left;">Vitalis V (2017)<a href="#tme12659-bib-0062" data-ref-type="ref">62</a></td><td style="text-align: left;">French armed forces Sahel</td><td style="text-align: left;">2016‐2017</td><td style="text-align: left;">To evaluate the practices of battlefield transfusion (RBC, plasma, FWB)</td><td style="text-align: left;">Severely injured receivers of PHT‐RBC or ‐plasma or ‐FWB</td><td style="text-align: left;">No battlefield transfusion</td><td style="text-align: left;">No</td><td style="text-align: left;">7<a href="#tme12659-note-0004" data-ref-type="fn">b</a> (4 of whom RBC)</td><td style="text-align: left;">POI + Role 1</td><td style="text-align: left;">Overall: Blunt: 1 (4%) Penetrating: 27 (96%) Explosion 16 (57%) Active external haemorrhage 12 (43%)</td><td style="text-align: left;"><p>PHT: 45 (33‐52)</p><p>Control: 25 (16‐22) <em>P</em> = .01</p></td></tr><tr class="even"><td style="text-align: left;">Retrospective comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="odd"><td style="text-align: left;">Howard, JT (2017)<a href="#tme12659-bib-0063" data-ref-type="ref">63</a></td><td style="text-align: left;">US military Afghanistan</td><td style="text-align: left;">2001‐2014</td><td style="text-align: left;">To evaluate potential influences on KIA mortality</td><td style="text-align: left;">Casualties who needed and received PHT</td><td style="text-align: left;">Casualties who needed but did not receive PHT</td><td style="text-align: left;">Adjusted data</td><td style="text-align: left;">75<a href="#tme12659-note-0005" data-ref-type="fn">c</a></td><td style="text-align: left;">Prehospital helicopter transport to FST or CSH</td><td style="text-align: left;"><p>Overall: Explosion: 65.1% Gunshot: 22.5%</p><p>Blunt or other: 11.4%</p></td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">O'Reilly DJ‐b (2014)<a href="#tme12659-bib-0064" data-ref-type="ref">64</a></td><td style="text-align: left;">UK MERT‐E Afghanistan</td><td style="text-align: left;">2006‐2011</td><td style="text-align: left;">To evaluate the effect of PHTRBC/PHT‐plasma on mortality</td><td style="text-align: left;">Receivers of PHTRBC and PHT‐plasma</td><td style="text-align: left;">Matched patients where no PHT available</td><td style="text-align: left;">Propensity score</td><td style="text-align: left;">97<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">POI + Role 1</td><td style="text-align: left;"><p>PHT: Blunt: 1% Penetrating: 99% Burn: 0% Explosive: 51.5% Gunshot wound: 47.4% Matched control: Blunt: 3.1% Penetrating: 96.9% Burn: 0% Explosive: 49.5%</p><p>Gunshot wound: 47.4%</p></td><td style="text-align: left;"><p>PHT:</p><p>16 (9‐25) Control:</p><p>16 (9‐24.5) <em>P</em> = .686</p></td></tr><tr class="odd"><td style="text-align: left;">Shackelford S (2017)<a href="#tme12659-bib-0065" data-ref-type="ref">65</a></td><td style="text-align: left;">UK MERT, US Air Force Pedro, US DUSTOFF, Afghanistan</td><td style="text-align: left;">2012‐2015</td><td style="text-align: left;">To examine the association of PHTRBC and/or PHT‐plasma and time to initial transfusion with injury survival</td><td style="text-align: left;">receivers of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">no PHT</td><td style="text-align: left;">frequency matched</td><td style="text-align: left;">55<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">POI to role 2 or 3</td><td style="text-align: left;"><p>PHT: Explosives 84% Gunshot wound 16%</p><p>≥1 AMputation: 73% Hemorrhagic torso injury 56%</p><p>Control: Explosives: 71% Gunshot wound: 29% <em>P</em> = .05</p><p>≥1 AMputation: 27% <em>P</em> &lt; .001 Hemorrhagic torso injury: 35% <em>P</em> = .004</p></td><td style="text-align: left;"><p>PHT:</p><p>29 (17‐36)</p><p>Control: 28.6 (24.0‐33.2) <em>P</em> = .88</p></td></tr><tr class="even"><td style="text-align: left;">Prospective not‐comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="odd"><td style="text-align: left;">Aye Maung N (2015)<a href="#tme12659-bib-0066" data-ref-type="ref">66</a></td><td style="text-align: left;">UK army Afghanistan</td><td style="text-align: left;">2012‐2014</td><td style="text-align: left;">To explore the utility and feasibility of forward transfusion of RBC</td><td style="text-align: left;">Missions where blood components were carried</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">2</td><td style="text-align: left;">POI + Role 1</td><td style="text-align: left;">Gunshot wound: 100% (<em>n</em> = 2)</td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Malsby RF (2013)<a href="#tme12659-bib-0067" data-ref-type="ref">67</a></td><td style="text-align: left;">US Army, Afghanistan</td><td style="text-align: left;">2012</td><td style="text-align: left;">Process improvement initiative of blood product transfusion on Urgent helicopter evacuation casualties</td><td style="text-align: left;">Receivers of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">15<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">POI + Role 1</td><td style="text-align: left;"><p>Explosion: 87%</p><p>Gunshot wound: 13%</p><p>≥1 AMputation: 60%</p></td><td style="text-align: left;">n/d</td></tr><tr class="odd"><td style="text-align: left;">Retrospective not‐comparative studies</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="even"><td style="text-align: left;">Barkana Y (1999)<a href="#tme12659-bib-0068" data-ref-type="ref">68</a></td><td style="text-align: left;">Israel Defense Force Medical Corps, Israel</td><td style="text-align: left;">1994‐1996</td><td style="text-align: left;">To characterise the different aspects of PHTRBC and to evaluate its potential effect on the morbidity and mortality</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">40</td><td style="text-align: left;">POI + Role 1</td><td style="text-align: left;">Blunt: 22.5% Penetrating: 77.5% Explosion: 47.5% Gunshot wounds: 22.5% Explosion + gunshot wounds: 7.5% MVC: 20% Fall from height: 2.5%</td><td style="text-align: left;">18 (11.5‐25)</td></tr><tr class="odd"><td style="text-align: left;">Chen J (2017)<a href="#tme12659-bib-0069" data-ref-type="ref">69</a></td><td style="text-align: left;">Israeli Air Force, Israel</td><td style="text-align: left;">2003‐2010</td><td style="text-align: left;">To describe PHTRBC, and to evaluate adherence to clinical practice guidelines</td><td style="text-align: left;">Receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">89</td><td style="text-align: left;">Scene+ interfacility</td><td style="text-align: left;">Combat: 69% Non‐combat: 31% Gunshot wounds: 36% MVC: 28% Explosions: 24% Stab wound: 4% Plane crash: 2% Fall from height: 2%</td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Edgar IA (2014)<a href="#tme12659-bib-0070" data-ref-type="ref">70</a></td><td style="text-align: left;">US and UK military, Afghanistan</td><td style="text-align: left;">2011</td><td style="text-align: left;">To compare initial management and early outcomes in patients suffering bilateral lower limb amputations and differences related to the type of aeromedical evacuation assets</td><td style="text-align: left;">Surviving adult male patients with bilateral traumatic lower limb amputations transferred by MERT in a CH‐47 Chinook helicopter</td><td style="text-align: left;">vs transferred by PEDRO in an HH‐60 Pavehawk helicopter.</td><td style="text-align: left;">n/a</td><td style="text-align: left;">n/d</td><td style="text-align: left;"><p>POI to</p><p>Role 3</p></td><td style="text-align: left;">Only patients with bilateral lower limb amputations</td><td style="text-align: left;"><p>NISS</p><p>MERT: 27 (range 19‐41)</p><p>PEDRO: 27 (range 22‐29) <em>P</em> = 1</p></td></tr><tr class="odd"><td style="text-align: left;">Morrison JJ (2013)<a href="#tme12659-bib-0071" data-ref-type="ref">71</a></td><td style="text-align: left;">US and UK military Afghanistan</td><td style="text-align: left;">2008‐2011</td><td style="text-align: left;">To characterise and compare mortality among casualties evacuated with conventional military retrieval (CMR) to those evacuated with an advanced medical retrieval (AMR) capability</td><td style="text-align: left;">Casualties evacuated from POI by an AMR capability</td><td style="text-align: left;">Vs those evacuated by a medic‐led CMR capability</td><td style="text-align: left;">n/a</td><td style="text-align: left;">162<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">POI to role 3</td><td style="text-align: left;"><p>AMR: Blast: 70.4% Gunshot: 24.3% Other: 5.3%</p><p>CMR: Blast: 60.8% <em>P</em> &lt; .001</p><p>Gunshot: 34.9% Other: 4.3%</p></td><td style="text-align: left;"><p>Mean (SD):</p><p>AMR: 16 (17)</p><p>CMR: 15 (16) <em>P</em> = .122</p></td></tr><tr class="even"><td style="text-align: left;">O'Reilly DJ‐a (2014)<a href="#tme12659-bib-0072" data-ref-type="ref">72</a></td><td style="text-align: left;">UK MERT‐E Afghanistan</td><td style="text-align: left;">2008‐2011</td><td style="text-align: left;">To present the initial experience of military PHTRBC and PHT‐plasma</td><td style="text-align: left;">Receivers of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">310<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">POI to role 2 or 3</td><td style="text-align: left;">Blunt: 1.0% Penetrating: 99% Burn: 0.3% Explosive: 72.9% Gunshot wound 25.8%</td><td style="text-align: left;">20 (16‐29)</td></tr><tr class="odd"><td style="text-align: left;">Powell‐Dunford N (2014)<a href="#tme12659-bib-0073" data-ref-type="ref">73</a></td><td style="text-align: left;">US Army, Afghanistan</td><td style="text-align: left;">2012</td><td style="text-align: left;">To enumerate the specific risks and risk management strategies of en route transfusion</td><td style="text-align: left;">Receivers of PHTRBC and/or PHT‐plasma</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">61<a href="#tme12659-note-0004" data-ref-type="fn">b</a> (54 of whom RBC)</td><td style="text-align: left;">n/d</td><td style="text-align: left;"><p>Explosion: 74%</p><p>Gunshot wound 26%</p></td><td style="text-align: left;">n/d</td></tr><tr class="even"><td style="text-align: left;">Shlaifer A (2017)<a href="#tme12659-bib-0074" data-ref-type="ref">74</a></td><td style="text-align: left;">Israeli Defense Forces, Israel</td><td style="text-align: left;">2013‐2016</td><td style="text-align: left;">To describe feasibility, safety, adverse reactions, and adherence to clinical practice guidelines in PHT‐plasma</td><td style="text-align: left;">Receivers of PHT‐plasma. Among them 9 receivers of PHTRBC</td><td style="text-align: left;">None</td><td style="text-align: left;">n/a</td><td style="text-align: left;">9<a href="#tme12659-note-0004" data-ref-type="fn">b</a></td><td style="text-align: left;">POI + Role 1</td><td style="text-align: left;"><p>Penetrating: 68.5% Blunt: 15.2%</p><p>Burn: 1.1% Blast: 1.1%</p><p>Combination: 14.1%</p></td><td style="text-align: left;">ISS 1‐8:10.9% ISS 9‐14:20.7% ISS 16‐24:28.3% 25‐75:40.1%</td></tr><tr class="odd"><td style="text-align: left;">Case reports</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr class="even"><td style="text-align: left;">West BC (2004)<a href="#tme12659-bib-0075" data-ref-type="ref">75</a></td><td style="text-align: left;">US Army Afghanistan</td><td style="text-align: left;">2004</td><td style="text-align: left;">Case report</td><td style="text-align: left;"></td><td style="text-align: left;"></td><td style="text-align: left;">n/a</td><td style="text-align: left;">1</td><td style="text-align: left;">POI to FST</td><td style="text-align: left;">Penetrating: 100% (<em>n</em> = 1)</td><td style="text-align: left;">n/d</td></tr></tbody></table>

*Note*: Median (IQR) unless otherwise specified.

Abbreviations: AMR, advanced medical retrieval; CC, clinically evident coagulopathic bleeding; CMR, conventional military retrieval; CSH, Combat Support Hospital; FFP, Fresh frozen plasma; FST, Forward Surgical Team; FWB, fresh whole blood; GI, gastro‐intestinal; HEMS, Helicopter Emergency Medical Service; ISS, Injury Severity Score; KIA, Killed in action; MAST, Medical antishock trousers; MERT(−E), Medical Emergency Response Team (−Enhanced); MVC, motor vehicle collision; n/a, not applicable; n/d, not described; n/s, not specified for PHTRBC; (N)ISS, (New) Injury Severity Score PHT, prehospital transfusion; PHTRBC, prehospital transfusion of red blood cells; PHT‐plasma, prehospital transfusion of plasma; POI, point of injury; RBC, red blood cells; RCT, randomised clinical trial; RTS, Revised trauma score; SD, SD; TIC, trauma induced coagulopathy; U, Units; UK, United Kingdom; USA, United States of America.

PHTRBC unless otherwise specified; matched number of patients if applicable.

PHTRBC and/or other prehospital blood component products.

blood products not specified.

We included 14 articles discussing PHTRBC in military medical services, of which four studies had a control population. Four articles reported prehospital transfusion as an additional topic, while primarily discussing another aspect of their study[70](#tme12659-bib-0070){ref-type="ref"}, [71](#tme12659-bib-0071){ref-type="ref"}, [74](#tme12659-bib-0074){ref-type="ref"}, [76](#tme12659-bib-0076){ref-type="ref"} (Table [1](#tme12659-tbl-0001){ref-type="table"}).

No randomised trials were identified; all studies were observational. The potential overlap of patients in different manuscripts was substantial (Tables [2](#tme12659-tbl-0002){ref-type="table"} and [3](#tme12659-tbl-0003){ref-type="table"}). The bias assessment of the studies is shown in Table [4](#tme12659-tbl-0004){ref-type="table"}.

###### 

Included civilian studies by region and medical service, making potential overlapping study populations visible

  Country                                                                                             Region                                                        First author (y)                                                                                    Comments                                           85   86   87   88   89   90   91   92   93   94   95   96   97   98   99   00   01   02   03   04   05   06   07   08   09   10   11   12   13   14   15   16   17   18   19   20
  --------------------------------------------------------------------------------------------------- ------------------------------------------------------------- --------------------------------------------------------------------------------------------------- -------------------------------------------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  Australia                                                                                           (Greater) Brisbane                                            Bodnar D‐b (2014)[41](#tme12659-bib-0041){ref-type="ref"}                                                                                                                                                                                                                                                                             
  Lawton LD (2012)[58](#tme12659-bib-0058){ref-type="ref"}                                            Case report                                                                                                                                                                                                                                                                                                                                                                                         
  (Greater) Sydney                                                                                    Garner AA (1999)[57](#tme12659-bib-0057){ref-type="ref"}      Case report                                                                                                                                                                                                                                                                                                                           
  Sherren PB (2013)[38](#tme12659-bib-0038){ref-type="ref"}                                           Exact period not specified                                                                                                                                                                                                                                                                                                                                                                          
  Victoria                                                                                            Heschl S (2018)[44](#tme12659-bib-0044){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                             
  Canada                                                                                              Br. Columbia                                                  Macnab AJ (1996)[59](#tme12659-bib-0059){ref-type="ref"}                                            Case report                                                                                                                                                                                                                       
  W. Canada                                                                                           Krook C (2018)[47](#tme12659-bib-0047){ref-type="ref"}        Shock Trauma Air Rescue Society (STARS)                                                                                                                                                                                                                                                                                               
  NL                                                                                                  Nijmegen, R\'dam                                              Peters J (2017)[33](#tme12659-bib-0033){ref-type="ref"}                                                                                                                                                                                                                                                                               
  Norway                                                                                              Bergen                                                        Sunde GA (2015)[55](#tme12659-bib-0055){ref-type="ref"}                                                                                                                                                                                                                                                                               
  UK                                                                                                  Kent, Surrey & Sussex                                         Griggs JE (2018)[30](#tme12659-bib-0030){ref-type="ref"}                                                                                                                                                                                                                                                                              
  Lyon R (2017)[49](#tme12659-bib-0049){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  London                                                                                              Rehn M (2018)[35](#tme12659-bib-0035){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                               
  Rehn M (2019)[36](#tme12659-bib-0036){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Weaver AE (2012)[39](#tme12659-bib-0039){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Scotland                                                                                            Reed M (2017)[24](#tme12659-bib-0024){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                               
  South West                                                                                          Hooper N (2017)[46](#tme12659-bib-0046){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                             
  Thames Valley                                                                                       Raitt JE (2018)[54](#tme12659-bib-0054){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                             
  USA                                                                                                 Alabama                                                       Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}                                              9 trauma centers                                                                                                                                                                                                                  
  Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}                                            9 trauma centers                                                                                                                                                                                                                                                                                                                                                                                    
  Arizona                                                                                             Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}        9 trauma centers                                                                                                                                                                                                                                                                                                                      
  Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}                                            9 trauma centers                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                      Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}     9 institutions                                                                                                                                                                                                                                                                                                                        
  California                                                                                          Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}        9 trauma centers                                                                                                                                                                                                                                                                                                                      
                                                                                                      Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}      9 trauma centers                                                                                                                                                                                                                                                                                                                      
  Connecticut                                                                                         Sumida MP (2000)[37](#tme12659-bib-0037){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                            
  Illinois                                                                                            Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}     9 institutions                                                                                                                                                                                                                                                                                                                        
                                                                                                      Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                              
  Maryland                                                                                            Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}      9 trauma centers                                                                                                                                                                                                                                                                                                                      
                                                                                                      Mena‐Munoz J (2016)[51](#tme12659-bib-0051){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                         
                                                                                                      Berns KS (1998)[40](#tme12659-bib-0040){ref-type="ref"}       Mayo HEMS                                                                                                                                                                                                                                                                                                                             
                                                                                                      Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}     9 institutions; Trauma only                                                                                                                                                                                                                                                                                                           
                                                                                                      Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}        9 trauma centers                                                                                                                                                                                                                                                                                                                      
                                                                                                      Fahy AS (2017)[43](#tme12659-bib-0043){ref-type="ref"}        Mayo One, Mayo Pediatric/Neonatal Transport; Pediatric patients only                                                                                                                                                                                                                                                                  
                                                                                                      Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}      9 trauma centers                                                                                                                                                                                                                                                                                                                      
                                                                                                      Minnesota                                                     Kim BD (2012)[22](#tme12659-bib-0022){ref-type="ref"}                                               Mayo HEMS; Trauma only                                                                                                                                                                                                            
                                                                                                      Mix FM (2018)[52](#tme12659-bib-0052){ref-type="ref"}         Mayo HEMS and ground EMS; Trauma only                                                                                                                                                                                                                                                                                                 
                                                                                                      Parker ME (2017)[32](#tme12659-bib-0032){ref-type="ref"}      Mayo HEMS; GI bleed only                                                                                                                                                                                                                                                                                                              
                                                                                                      Potter D (2015)[53](#tme12659-bib-0053){ref-type="ref"}       Mayo HEMS; Pediatric patients only                                                                                                                                                                                                                                                                                                    
                                                                                                      Thiels CA (2016)[56](#tme12659-bib-0056){ref-type="ref"}      Mayo HEMS                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                    Trembley AL (2016)[60](#tme12659-bib-0060){ref-type="ref"}                                          North Memorial Air Care; Description of protocol                                                                                                                                                                                  
                                                                                                      New England                                                   Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"} [a](#tme12659-note-0007){ref-type="fn"}   9 institutions                                                                                                                                                                                                                    
  Higgins GL (2012)[45](#tme12659-bib-0045){ref-type="ref"} [b](#tme12659-note-0008){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                       
  Wheeler R (2013)[23](#tme12659-bib-0023){ref-type="ref"} [c](#tme12659-note-0009){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                      Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}        9 trauma centers                                                                                                                                                                                                                                                                                                                      
                                                                                                      Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}      9 trauma centers                                                                                                                                                                                                                                                                                                                      
  Ohio                                                                                                Krugh D (1994)[48](#tme12659-bib-0048){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                              
                                                                                                      Mena‐Munoz J (2016)[51](#tme12659-bib-0051){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                         
  Oregon                                                                                              Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}        9 trauma centers                                                                                                                                                                                                                                                                                                                      
  Dalton AM (1993)[42](#tme12659-bib-0042){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}                                            9 trauma centers                                                                                                                                                                                                                                                                                                                                                                                    
  Price DD (1999)[34](#tme12659-bib-0034){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Pennsylvania                                                                                        Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}     9 institutions                                                                                                                                                                                                                                                                                                                        
  Brown JB‐b (2015)[29](#tme12659-bib-0029){ref-type="ref"}                                           STAT MedEvac                                                                                                                                                                                                                                                                                                                                                                                        
  Mena‐Munoz J (2016)[51](#tme12659-bib-0051){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Tennessee                                                                                           Miller B (2016)[31](#tme12659-bib-0031){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                             
  Sumida MP (2000)[37](#tme12659-bib-0037){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                      Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}     9 institutions                                                                                                                                                                                                                                                                                                                        
                                                                                                      Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}        9 trauma centers                                                                                                                                                                                                                                                                                                                      
  Texas                                                                                               Henriksen H (2016)[26](#tme12659-bib-0026){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                          
                                                                                                      Holcomb JB‐b (2015)[18](#tme12659-bib-0018){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                         
                                                                                                      Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}      9 trauma centers                                                                                                                                                                                                                                                                                                                      
                                                                                                      Vartanian, L (2017)[61](#tme12659-bib-0061){ref-type="ref"}   Cypress Creek EMS; Description of protocol                                                                                                                                                                                                                                                                                            
                                                                                                      Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}     9 institutions                                                                                                                                                                                                                                                                                                                        
                                                                                                      Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}        9 trauma centers                                                                                                                                                                                                                                                                                                                      
  Washington                                                                                          Dalton AM (1993)[42](#tme12659-bib-0042){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                            
                                                                                                      Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}      9 trauma centers                                                                                                                                                                                                                                                                                                                      
                                                                                                      Maher P (2017)[50](#tme12659-bib-0050){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                              
  Wisconsin                                                                                           Trembley AL (2016)[60](#tme12659-bib-0060){ref-type="ref"}    North Memorial Air Care; Description of protocol                                                                                                                                                                                                                                                                                      

Abbreviations: NL, the Netherlands; P.‐A.‐C. d\'A., Provence‐Alpes‐Côte‐d\'Azur; R\'dam, Rotterdam.

Massachusetts General Hospital.

Lewiston and Bangor, LifeFlight of Maine.

Dartmouth‐Hitchcock Medical Center, Lebanon, New Hampshire.

###### 

Included military studies by region and medical service, making potential overlapping study populations visible

  Subject                                                                                 First author (y)                        Comments   94   95   96   97   98   99   00   01   02   03   04   05   06   07   08   09   10   11   12   13   14   15   16   17
  ----------------------------------------------------------------- ------------------------------------------------------------ ---------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  UK‐MERT Afghanistan                                                Aye Maung N (2015)[66](#tme12659-bib-0066){ref-type="ref"}                                                                                                                                
  Edgar IA (2014)[70](#tme12659-bib-0070){ref-type="ref"}                                                                                                                                                                                                      
  Morrison JJ (2013)[71](#tme12659-bib-0071){ref-type="ref"}                                                                                                                                                                                                   
  O\'Reilly DJ‐b (2014)[64](#tme12659-bib-0064){ref-type="ref"}                                                                                                                                                                                                
  O\'Reilly DJ‐a (2014)[72](#tme12659-bib-0072){ref-type="ref"}                                                                                                                                                                                                
  Shackelford S (2017)[65](#tme12659-bib-0065){ref-type="ref"}                                                                                                                                                                                                 
  USA Afghanistan                                                     Edgar IA (2014)[70](#tme12659-bib-0070){ref-type="ref"}      Pedro                                                                                                                       
  Howard, JT (2017)[63](#tme12659-bib-0063){ref-type="ref"}                               All helicopters                                                                                                                                                      
  Malsby RF (2013)[67](#tme12659-bib-0067){ref-type="ref"}                                    Dustoff                                                                                                                                                          
  Morrison JJ (2013)[71](#tme12659-bib-0071){ref-type="ref"}                               Pedro/Dustoff                                                                                                                                                       
  Shackelford S (2017)[65](#tme12659-bib-0065){ref-type="ref"}                             Pedro/Dustoff                                                                                                                                                       
  Powell‐Dunford N (2014)[73](#tme12659-bib-0073){ref-type="ref"}                        Medevac helicopter                                                                                                                                                    
  West BC (2004)[75](#tme12659-bib-0075){ref-type="ref"}                                    Case report                                                                                                                                                        
  France Sahel                                                        Vitalis V (2017)[62](#tme12659-bib-0062){ref-type="ref"}                                                                                                                                 
  Israel                                                              Barkana Y (1999)[68](#tme12659-bib-0068){ref-type="ref"}                                                                                                                                 
  Chen J (2017)[69](#tme12659-bib-0069){ref-type="ref"}                                                                                                                                                                                                        
  Shlaifer A (2017)[74](#tme12659-bib-0074){ref-type="ref"}                                                                                                                                                                                                    

Abbreviations: MERT, Medical Emergency Response Team; UK, United Kingdom; USA, United States of America.

###### 

Risk of bias assessment, Newcastle‐Ottawa Scale

  First author (y)                                                Selection   Comparability   Outcome
  --------------------------------------------------------------- ----------- --------------- ---------
  Civilian services                                                                           
  Prospective comparative studies                                                             
  Henriksen H (2016)[26](#tme12659-bib-0026){ref-type="ref"}      ★★                          ★★
  Holcomb J (2017)[27](#tme12659-bib-0027){ref-type="ref"}        ★★★         ★★              ★★
  Retrospective comparative studies                                                           
  Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}       ★★★         ★★              ★★
  Brown JB‐b (2015)[29](#tme12659-bib-0029){ref-type="ref"}       ★★★★        ★★              ★★
  Griggs JE (2018)[30](#tme12659-bib-0030){ref-type="ref"}        ★★★★        ★★              ★★★
  Holcomb JB‐b (2015)[18](#tme12659-bib-0018){ref-type="ref"}     ★★★         ★★              ★★
  Kim BD (2012)[22](#tme12659-bib-0022){ref-type="ref"}           ★★★                         ★★
  Miller B (2016)[31](#tme12659-bib-0031){ref-type="ref"}         ★★          ★★              ★★
  Parker ME (2017)[32](#tme12659-bib-0032){ref-type="ref"}        ★★★                         ★★
  Peters J (2017)[33](#tme12659-bib-0033){ref-type="ref"}         ★★★                         ★★
  Price DD (1999)[34](#tme12659-bib-0034){ref-type="ref"}         ★★          ★               ★★
  Rehn M (2018)[35](#tme12659-bib-0035){ref-type="ref"}           ★★★★        ★               ★★
  Rehn M (2019)[36](#tme12659-bib-0036){ref-type="ref"}           ★★★         ★               ★★★
  Sumida MP (2000)[37](#tme12659-bib-0037){ref-type="ref"}        ★★★                         ★
  Military services                                                                           
  Prospective comparative studies                                                             
  Vitalis V (2017)[62](#tme12659-bib-0062){ref-type="ref"}        ★★★★                        ★★★
  Retrospective comparative studies                                                           
  Howard, JT (2017)[63](#tme12659-bib-0063){ref-type="ref"}       ★★★         ★               ★★
  O\'Reilly DJ‐b (2014)[64](#tme12659-bib-0064){ref-type="ref"}   ★★★         ★               ★★
  Shackelford S (2017)[65](#tme12659-bib-0065){ref-type="ref"}    ★★          ★★              ★★★

3.2. *Patient characteristics* {#tme12659-sec-0008}
------------------------------

In total, 47 civilian studies reported on trauma patients. Blunt injury was most prevalent in the included studies, ranging from 55% to 100% of trauma patients.[18](#tme12659-bib-0018){ref-type="ref"}, [22](#tme12659-bib-0022){ref-type="ref"}, [24](#tme12659-bib-0024){ref-type="ref"}, [25](#tme12659-bib-0025){ref-type="ref"}, [26](#tme12659-bib-0026){ref-type="ref"}, [27](#tme12659-bib-0027){ref-type="ref"}, [28](#tme12659-bib-0028){ref-type="ref"}, [29](#tme12659-bib-0029){ref-type="ref"}, [30](#tme12659-bib-0030){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"}, [35](#tme12659-bib-0035){ref-type="ref"}, [36](#tme12659-bib-0036){ref-type="ref"}, [38](#tme12659-bib-0038){ref-type="ref"}, [41](#tme12659-bib-0041){ref-type="ref"}, [42](#tme12659-bib-0042){ref-type="ref"}, [43](#tme12659-bib-0043){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"}, [52](#tme12659-bib-0052){ref-type="ref"}, [53](#tme12659-bib-0053){ref-type="ref"}, [54](#tme12659-bib-0054){ref-type="ref"}, [55](#tme12659-bib-0055){ref-type="ref"}, [57](#tme12659-bib-0057){ref-type="ref"}, [58](#tme12659-bib-0058){ref-type="ref"}, [61](#tme12659-bib-0061){ref-type="ref"} The mean or median injury severity score (ISS) varied from 18 to 43 (Table [1](#tme12659-tbl-0001){ref-type="table"}).[18](#tme12659-bib-0018){ref-type="ref"}, [22](#tme12659-bib-0022){ref-type="ref"}, [23](#tme12659-bib-0023){ref-type="ref"}, [24](#tme12659-bib-0024){ref-type="ref"}, [25](#tme12659-bib-0025){ref-type="ref"}, [26](#tme12659-bib-0026){ref-type="ref"}, [27](#tme12659-bib-0027){ref-type="ref"}, [28](#tme12659-bib-0028){ref-type="ref"}, [29](#tme12659-bib-0029){ref-type="ref"}, [30](#tme12659-bib-0030){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"}, [35](#tme12659-bib-0035){ref-type="ref"}, [37](#tme12659-bib-0037){ref-type="ref"}, [41](#tme12659-bib-0041){ref-type="ref"}, [42](#tme12659-bib-0042){ref-type="ref"}, [43](#tme12659-bib-0043){ref-type="ref"}, [44](#tme12659-bib-0044){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"}, [53](#tme12659-bib-0053){ref-type="ref"}, [54](#tme12659-bib-0054){ref-type="ref"}, [57](#tme12659-bib-0057){ref-type="ref"} The most frequent mechanisms of injury were motor vehicle collisions (42%‐88%) [30](#tme12659-bib-0030){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"}, [35](#tme12659-bib-0035){ref-type="ref"}, [38](#tme12659-bib-0038){ref-type="ref"}, [41](#tme12659-bib-0041){ref-type="ref"}, [42](#tme12659-bib-0042){ref-type="ref"}, [43](#tme12659-bib-0043){ref-type="ref"}, [44](#tme12659-bib-0044){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"}, [54](#tme12659-bib-0054){ref-type="ref"}, [61](#tme12659-bib-0061){ref-type="ref"} and falls from a height (3.4%‐13%).[30](#tme12659-bib-0030){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"}, [35](#tme12659-bib-0035){ref-type="ref"}, [38](#tme12659-bib-0038){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"}, [54](#tme12659-bib-0054){ref-type="ref"}, [61](#tme12659-bib-0061){ref-type="ref"}

In military services, penetrating injuries were reported by 68% to 100% of studies [62](#tme12659-bib-0062){ref-type="ref"}, [64](#tme12659-bib-0064){ref-type="ref"}, [66](#tme12659-bib-0066){ref-type="ref"}, [68](#tme12659-bib-0068){ref-type="ref"}, [72](#tme12659-bib-0072){ref-type="ref"}, [74](#tme12659-bib-0074){ref-type="ref"}, [75](#tme12659-bib-0075){ref-type="ref"}, [76](#tme12659-bib-0076){ref-type="ref"} and the mean or median ISS varied from 15 to 45 (Table [1](#tme12659-tbl-0001){ref-type="table"}).[62](#tme12659-bib-0062){ref-type="ref"}, [64](#tme12659-bib-0064){ref-type="ref"}, [65](#tme12659-bib-0065){ref-type="ref"}, [68](#tme12659-bib-0068){ref-type="ref"}, [70](#tme12659-bib-0070){ref-type="ref"}, [71](#tme12659-bib-0071){ref-type="ref"}, [72](#tme12659-bib-0072){ref-type="ref"} The most frequently reported mechanisms of injury were explosions (1%‐87%)[62](#tme12659-bib-0062){ref-type="ref"}, [64](#tme12659-bib-0064){ref-type="ref"}, [65](#tme12659-bib-0065){ref-type="ref"}, [67](#tme12659-bib-0067){ref-type="ref"}, [68](#tme12659-bib-0068){ref-type="ref"}, [69](#tme12659-bib-0069){ref-type="ref"}, [71](#tme12659-bib-0071){ref-type="ref"}, [72](#tme12659-bib-0072){ref-type="ref"}, [73](#tme12659-bib-0073){ref-type="ref"}, [74](#tme12659-bib-0074){ref-type="ref"}, [76](#tme12659-bib-0076){ref-type="ref"} and gunshot wounds (13%‐100%).[64](#tme12659-bib-0064){ref-type="ref"}, [65](#tme12659-bib-0065){ref-type="ref"}, [66](#tme12659-bib-0066){ref-type="ref"}, [67](#tme12659-bib-0067){ref-type="ref"}, [68](#tme12659-bib-0068){ref-type="ref"}, [69](#tme12659-bib-0069){ref-type="ref"}, [71](#tme12659-bib-0071){ref-type="ref"}, [72](#tme12659-bib-0072){ref-type="ref"}, [73](#tme12659-bib-0073){ref-type="ref"}, [76](#tme12659-bib-0076){ref-type="ref"}

Data on non‐trauma patients were reported in 16 civilian studies and made up 3% to 100% of these study cohorts.[32](#tme12659-bib-0032){ref-type="ref"}, [40](#tme12659-bib-0040){ref-type="ref"}, [43](#tme12659-bib-0043){ref-type="ref"}, [44](#tme12659-bib-0044){ref-type="ref"}, [45](#tme12659-bib-0045){ref-type="ref"}, [46](#tme12659-bib-0046){ref-type="ref"}, [47](#tme12659-bib-0047){ref-type="ref"}, [48](#tme12659-bib-0048){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"}, [50](#tme12659-bib-0050){ref-type="ref"}, [51](#tme12659-bib-0051){ref-type="ref"}, [54](#tme12659-bib-0054){ref-type="ref"}, [55](#tme12659-bib-0055){ref-type="ref"}, [56](#tme12659-bib-0056){ref-type="ref"}, [59](#tme12659-bib-0059){ref-type="ref"}, [61](#tme12659-bib-0061){ref-type="ref"} Suspected gastro‐intestinal bleeding or ruptured aortic aneurysm were the most often reported non‐traumatic diagnoses in transfused patients. Only one article reported on non‐trauma patients attended to by military services; the two patients were transferred between facilities and suffered from obstetric haemorrhage or respiratory disease, they accounted for 2% of transfused patients.[69](#tme12659-bib-0069){ref-type="ref"}

3.3. *Outcome---Mortality* {#tme12659-sec-0009}
--------------------------

### 3.3.1. Civilian {#tme12659-sec-0010}

Unadjusted data from one study suggested that less PHTRBC patients died compared with non‐receivers,[37](#tme12659-bib-0037){ref-type="ref"} while another unadjusted study found no difference.[32](#tme12659-bib-0032){ref-type="ref"}

In propensity score‐matched trauma patients, Brown et al[28](#tme12659-bib-0028){ref-type="ref"}, [29](#tme12659-bib-0029){ref-type="ref"} found a significant advantage of PHTRBC on either 24 hours or 30 day mortality in two different studies, with 50 and 240 transfused patients, respectively. Rehn et al[36](#tme12659-bib-0036){ref-type="ref"} found a lower prehospital mortality in trauma patients transported from the scene. After adjustment, Holcomb et al[18](#tme12659-bib-0018){ref-type="ref"} found lower odds of mortality in critical trauma patients who received PHTRBC and/or plasma at 6 hours.

However, in six other studies reporting matched or adjusted data, no significant effect on mortality was found, either at 3 hours,[27](#tme12659-bib-0027){ref-type="ref"} 6 hours,[26](#tme12659-bib-0026){ref-type="ref"}, [30](#tme12659-bib-0030){ref-type="ref"} 24 hours,[26](#tme12659-bib-0026){ref-type="ref"}, [27](#tme12659-bib-0027){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"} 28 days[30](#tme12659-bib-0030){ref-type="ref"} or 30 days post‐infusion,[27](#tme12659-bib-0027){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"} for in‐hospital mortality[26](#tme12659-bib-0026){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"} or overall mortality[34](#tme12659-bib-0034){ref-type="ref"} (Table [5](#tme12659-tbl-0005){ref-type="table"}). Conversely, Kim et al[22](#tme12659-bib-0022){ref-type="ref"} found significantly lower mortality at 24 hours and a lower mortality overall for patients transfused with both PHT‐plasma and PHTRBC compared with patients receiving PHTRBC only. These studies varied in patient and injury characteristics, type of transport (from scene/ interfacility/ both), type of blood products used (RBC only or a combination of blood products), transfusion criteria as well as outcome measures, and therefore, data could not be meaningfully combined in a meta‐analysis.

###### 

Outcomes

+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| First author (y)                                                                                                                                                                                                                                                                                       | Mortality (*n* \[%\])                                                                                           | Shock on arrival to hospital[a](#tme12659-note-0013){ref-type="fn"}                                                                                                       | 24 h RBC requirement (U)                                                                                                           | ICU/hospital LOS (d)                                                                                                                                                        | TIC[a](#tme12659-note-0013){ref-type="fn"}                                                                              | Adverse events                                                                                                         |
+:=======================================================================================================================================================================================================================================================================================================+:================================================================================================================+:==========================================================================================================================================================================+:===================================================================================================================================+:============================================================================================================================================================================+:========================================================================================================================+:=======================================================================================================================+
| Civilian services                                                                                                                                                                                                                                                                                      |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Prospective comparative studies                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Henriksen H (2016)[26](#tme12659-bib-0026){ref-type="ref"}                                                                                                                                                                                                                                             | PHT vs control                                                                                                  |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 6 h: 10 (13.3%) vs 15 (8.3%) *P* = .210                                                                                                                                                                                                                                                                | **SBP: 90 (77‐113) vs 100 (80‐125) *P* = .044**                                                                 | **10 (4‐15) vs 4 (2‐9) *P* \< .001**                                                                                                                                      | n/d                                                                                                                                | **rTEG MA: 62 vs 64 *P* = .02**                                                                                                                                             | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 24 h: 12 (16%) vs 19 (10.4%) *P* = .213                                                                                                                                                                                                                                                                | DBP: 59 (50‐69) vs 60 (48‐76) *P* = .299                                                                        |                                                                                                                                                                           |                                                                                                                                    | **G‐value: 8.1 vs 8.69 *P* = .009**                                                                                                                                         |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| In‐hospital: 20(26.7%) vs 38(20.9%) *P* = .313                                                                                                                                                                                                                                                         | HR: 111 (90‐133) vs 108 (85‐130) *P* = .425                                                                     |                                                                                                                                                                           |                                                                                                                                    | ACT: 121 vs 121                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **pH: 7.21 (7.06‐7.32) vs 7.27 (7.18‐7.33) *P* = .002**                                                         |                                                                                                                                                                           |                                                                                                                                    | R‐time: 0.8 vs 0.8 K‐time: 1.65 vs 1.45 Angle: 70 vs 73 Ly30: 1 vs 1.4                                                                                                      |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | BE: −6 (−10 ‐ −3) vs −4 (−10 ‐ −1) *P* = .073                                                                   |                                                                                                                                                                           |                                                                                                                                    | Adjusting for PH‐RBC, PHT‐plasma associated with increased rTEG MA: **1 U increase in PH‐plasma was associated with (β coefficient) 13.95 mm (95%CI 3.13‐24.77 *P* = .012** |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Henriksen H (2016)[26](#tme12659-bib-0026){ref-type="ref"}                                                                                                                                                                                                                                             | PHT vs control, matched                                                                                         |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 3 h: 4 (9.3%) vs 8 (12.1%) OR 0.74 (95% CI 0.24‐2.26) *P* = .60                                                                                                                                                                                                                                        | n/d                                                                                                             | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 24 h: 5 (11.6%) vs 10 (15.2%) OR 0.74 (95% CI 0.25‐2.17) *P* = .58                                                                                                                                                                                                                                     |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 30d: 8 (18.6%) vs 14 (21.2%) OR 0.85 (95% CI 0.32‐2.28) *P* = .75                                                                                                                                                                                                                                      |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Retrospective comparative studies                                                                                                                                                                                                                                                                      |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Brown JB‐a (2015)[28](#tme12659-bib-0028){ref-type="ref"}                                                                                                                                                                                                                                              | PHTRBC vs control, matched                                                                                      |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| **24 h: OR 0.02 (95% CI 0.01‐0.69) *P* = .04 30d: HR 0.12 (95% CI 0.03‐0.61) *P* = .01** *Scene patients*:                                                                                                                                                                                             | **Admission hypotension: 60% vs 74% *P* = .02**                                                                 | **14.0 (7.0‐21.7) vs 8.3 (3.4‐18.5) *P* = .03**                                                                                                                           | n/d                                                                                                                                | **I**NR \> 1.5 OR = 0.01 (95% CI 0.01‐0.95) *P* = .05                                                                                                                       | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 24 h: OR = 0.04 (95% CI 0.01‐1.12) *P* = .059                                                                                                                                                                                                                                                          | BE −10 (−5 ‐ ‐12) vs −9 (−7 ‐ ‐12) *P* = .88                                                                    |                                                                                                                                                                           |                                                                                                                                    | Scene only: OR = 0.08 (95% CI 0.01‐1.35) *P* = .079                                                                                                                         |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **30d: HR = 0.11 (95% CI 0.02‐0.54) *P* \< .01**                                                                                                                                                                                                                                                       |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Brown JB‐b (2015)[29](#tme12659-bib-0029){ref-type="ref"}                                                                                                                                                                                                                                              | PHTRBC vs control, matched                                                                                      |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 24 h: 53 (22%) vs 86 (18%) *P* = .16                                                                                                                                                                                                                                                                   | SBP 106 (80‐132) vs 110 (91‐130) *P* = .07                                                                      | 5 (2‐11) vs 4 (2‐9) *P* = .06                                                                                                                                             | n/d                                                                                                                                | **INR: 1.4 (1.2‐1.9) vs 1.2 (1.1‐1.6) *P* \< .01**                                                                                                                          | ARDS: 5 (2%) vs 14 (3%) *P* = .61                                                                                       |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **In‐hospital: 74 (31%) vs 115 (24%) *P* = .03 24 h survival: AOR 4.91 (95% CI 1.51‐16.04) *P* = .01**                                                                                                                                                                                                 | **"Shock on admission"; 139 (58%) vs 226 (47%) *P* \< .01 AOR 0.28 (95% CI 0.09‐0.85) *P* = .03**               | *Matched scene patients*:                                                                                                                                                 |                                                                                                                                    | **TIC: 113 (47%) vs 149 (31%) *P* \< .01** AOR: 1.39 (95% CI 0.87‐2.24) *P* = .17                                                                                           | *Matched scene patients*:                                                                                               |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| In‐hospital survival: AOR 1.06 (95% CI 0.42‐2.61) *P* = .90                                                                                                                                                                                                                                            | *Matched scene patients*:                                                                                       | 8 (2‐18) vs 9 (3‐13) *P* = .66                                                                                                                                            |                                                                                                                                    | *Matched scene patients*:                                                                                                                                                   | ARDS: 3 (4%) vs 1 (1%) *P* = .07                                                                                        |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| *Matched scene patients*:                                                                                                                                                                                                                                                                              | **SBP 82 (60‐92) vs 104 (81‐126) *P* = .01**                                                                    | **\>4 U lower requirement; Coefficient − 4.5 U (95% CI ‐8.3 to −0.7) *P* = .02**                                                                                          |                                                                                                                                    | **INR 1.5 (1.2‐2.0) vs 1.3 (1.2‐1.6) *P* = .04**                                                                                                                            | PH transfusion reactions: none                                                                                          |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 24 h: 23 (32%) vs 37 (6%) *P* = .33                                                                                                                                                                                                                                                                    | "Shock on admission": 51 (72%) vs 99 (70%) *P* = .74 **AOR 0.24 (95% CI 0.07‐0.80) *P* = .02**                  |                                                                                                                                                                           |                                                                                                                                    | TIC: 37 (52%) vs 51 (36%) *P* = .06 AOR 2.02 (95% CI 0.53‐7.71) *P* = .30                                                                                                   | IH transfusion reactions: 1                                                                                             |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| In‐hospital: 26 (37%) vs 48 (34%) *P* = .68 **24 h survival: AOR 6.31 (95% CI 1.88‐21.14) *P* \< .01**                                                                                                                                                                                                 |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| In‐hospital survival: AOR 4.32 (95% CI 0.76‐24.72) *P* = .10                                                                                                                                                                                                                                           |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Griggs JE (2018)[30](#tme12659-bib-0030){ref-type="ref"}                                                                                                                                                                                                                                               | PHTRBC vs control                                                                                               |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 6 h 10 (10%) vs 19 (18%) *P* = .2 AOR 0.48 (95% CI 0.19‐1.19) *P* = .11                                                                                                                                                                                                                                | n/d                                                                                                             | 3 (1‐8) vs 4.5 (2‐9) (no analysis) **≥4 units RBC in 24 h: 41 (40%) vs 62 (60%) *P* = .02**                                                                               | n/d                                                                                                                                | n/d                                                                                                                                                                         | No immediate transfusion complications                                                                                  |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 28d: 21 (26%) vs 31 (40%), *P* = .09 AOR 0.66 (95% CI 0.32‐1.35) *P* = .26                                                                                                                                                                                                                             |                                                                                                                 | ≥10 units PRBC in 24 h: 14 (15%) vs 22 (22%) *P* = .31                                                                                                                    |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Holcomb JB‐b (2015)[18](#tme12659-bib-0018){ref-type="ref"}                                                                                                                                                                                                                                            | PHT vs control:                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 6 h: 12% vs 10% *P* = .425 Adjusted: OR 0.23 (95%CI 0.106‐1.056) *P* = .088                                                                                                                                                                                                                            | SBP: 115 (90‐135) vs 112 (90‐138) *P* = .944                                                                    | 6 h RBC: 0 (0‐4) vs 1 (0‐5) *P* = .370                                                                                                                                    | n/d                                                                                                                                | ACT: 113 (105‐128) vs 121 (105‐128) *P* = .546                                                                                                                              | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 24 h: 14% vs 13% *P* = .529 Adjusted: OR 0.57 *P* = .176                                                                                                                                                                                                                                               | HR on arrival: 96 (78‐116) vs 98 (80‐116) *P* = .649                                                            | **Adjusted: Coefficient**                                                                                                                                                 |                                                                                                                                    | α‐angle: 73 (69‐76) vs 72 (68‐76) *P* = .362                                                                                                                                |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 30‐d: 22% vs 21% *P* = .626 Adjusted: OR 0.80 *P* = .478                                                                                                                                                                                                                                               | **BE: −3 (−6‐0) vs − 4 (−8 ‐ ‐1) *P* = .002**                                                                   | **6 h transfusion: −3.72 (95% CI − 6.783 ‐ − 0.659) *P* = .017**                                                                                                          |                                                                                                                                    | mA(mm): 64 (59‐68) vs 64 (59‐67) *P* = .270                                                                                                                                 |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **Adjusted, in critical patients: coefficient: 6 h: 0.23 (95% CI 0.062‐0.890) *P* = .033** 24 h: OR 0.57 *P* = .117 30d: OR 0.71 *P* = .441                                                                                                                                                            | **pH: 7.30 (7.22‐7.35) vs 7.26 (7.19‐7.32) *P* = .003**                                                         | **24 h transfusion: −3.64 − (95% CI 7.100 to −0.192) *P* = .039**                                                                                                         |                                                                                                                                    | LY30(%): 1.1 (0.2‐2.7) vs 1.3 (0.3‐2.9) *P* = .568                                                                                                                          |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Kim BD (2012)[22](#tme12659-bib-0022){ref-type="ref"}                                                                                                                                                                                                                                                  | PHT‐plasma+RBC vs PHTRBC:                                                                                       |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 6 h: 11% vs 4% *P* = .422                                                                                                                                                                                                                                                                              | SBP: 89 vs 109 *P* = .057                                                                                       | 12.7 vs 11.4 *P* = .694                                                                                                                                                   | ICU: 6.3 vs 7.7 *P* = .672                                                                                                         | **INR baseline: 2.6 vs 1.5 *P* = .004**                                                                                                                                     | ARDS: 11% vs 8% *P* = .758                                                                                              |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **24 h: 44% vs 10% *P* = .026**                                                                                                                                                                                                                                                                        | HR: 100 vs 109 *P* = .324                                                                                       |                                                                                                                                                                           | Hospital: 11 vs 17 *P* = .352                                                                                                      | **INR Arrival: 1.6 vs 1.3 *P* = .001** Change in INR[b](#tme12659-note-0014){ref-type="fn"}: 0.9 vs 0.2 *P* = .078                                                          | ARF: 0% vs 4% *P* = .600                                                                                                |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **Overall: 56% vs 18% *P* = .023**                                                                                                                                                                                                                                                                     | Lactate: 5.2 vs 4.4 *P* = .472                                                                                  |                                                                                                                                                                           |                                                                                                                                    | **Arrival aPTT: 51 vs 35 *P* = .037**                                                                                                                                       |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | BE: −8.3 vs −8.4 *P* = .940                                                                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | pH: 7.19 vs 7.22 *P* = .634                                                                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Miller B (2016)[31](#tme12659-bib-0031){ref-type="ref"}                                                                                                                                                                                                                                                | PHTRBC vs control, matched:                                                                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 24 h: 39 (20%) vs 31 (16%) *P* = .291                                                                                                                                                                                                                                                                  | **SBP: 92.0 (77.2‐112.5) vs 110 (88.0‐124.0) *P* \< .001**                                                      | **6 (2‐12) vs 3 (0‐8) *P* \< .001**                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| In‐hospital: 59 (30%) vs 48 (25%) *P* = .212                                                                                                                                                                                                                                                           | HR: 103 (84‐123) vs 106 (88‐122) *P* = .363                                                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| *Adjusted*:                                                                                                                                                                                                                                                                                            |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 24 h: OR 1.04 (95% CI 0.54‐1.98) *P* = .91                                                                                                                                                                                                                                                             |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| In‐hospital: OR 1.05 (95% CI 0.56‐1.96) *P* = .88                                                                                                                                                                                                                                                      |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Parker ME (2017)[32](#tme12659-bib-0032){ref-type="ref"}                                                                                                                                                                                                                                               | PHT vs control:                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 30d: 13% vs 12% *P* = 1.00                                                                                                                                                                                                                                                                             | *Pre vs post transport (mean SD)*: *PHT*:                                                                       | *PHT vs control*:                                                                                                                                                         | Hospital: 5.0 (4.0‐8.0) vs 6.0 (4.0‐8.0) *P* = .52 ICU: 2.0 (1.0‐2.0) vs 2.0 (1.0‐3.0) *P* = .69                                   | *Pre vs post transport (mean ± SD)*: *PHT*: INR 2.01 ± 1.51 vs 1.56 ± 0.83 *P* = .01                                                                                        | TRALI: 1                                                                                                                |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | HCO3 (mmol/L): 23.20 ± 5.14 vs 22.41 ± 4.35 *P* = .27. Hemodynamic instability 55 (49%) vs 20 (18%) *P* \< .001 | Any RBC in‐hospital: 96 (86%) vs 40 (82%) *P* = .6                                                                                                                        |                                                                                                                                    | *Control*: INR 1.94 ± 0.97 vs 1.62 ± 1.37 *P* = .32                                                                                                                         |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | *Control*:                                                                                                      | In‐hospital RBC: 4.0 (2.0‐6.0) vs 3.0 (2.0‐6.0) *P* = .84                                                                                                                 |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | HCO3 (mmol/L) 23.67 ± 6.89 vs 21.90 ± 4.15 *P* = .29                                                            |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | Hemodynamic instability (%) 47 vs 18 *P* = .005                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Peters J (2017)[33](#tme12659-bib-0033){ref-type="ref"}                                                                                                                                                                                                                                                | PHTRBC vs control, matched:                                                                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 24 h: 19 (30%) vs 16 (32%) *P* = .531                                                                                                                                                                                                                                                                  | BE: − 9.9 (−25.0 to −0.7) vs − 6.6 (−23.2 to −0.6) *P* = .628                                                   | **1443 mL (range: 0‐19 315 mL) vs 2240 mL (range: 0‐15 120 mL) *P* = .004**                                                                                               | n/d                                                                                                                                | INR: 1.3 (range 1‐10) vs 1.3 (range 1‐3.1) *P* = .529                                                                                                                       | PH transfusion reactions: none                                                                                          |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 30d: 22 (45%) vs 20 (40%) *P* = .547                                                                                                                                                                                                                                                                   | Lactate (mmol/l): 3.6 (0.8‐21) vs 3.2 (1.1‐14.2) *P* = .142                                                     | 24 h RBC including PH volume: 1958 mL (range: 270‐20 580) vs 2240 mL (range: 0‐15 120) *P* = .888                                                                         |                                                                                                                                    | TIC: 14(40%) vs 10(26%) *P* = .188                                                                                                                                          | IH transfusion reactions: 1                                                                                             |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | "Shock on admission": 26 (70%) vs 26 (58%) *P* = .243                                                           |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Price DD (1999)[34](#tme12659-bib-0034){ref-type="ref"}                                                                                                                                                                                                                                                | PHTRBC vs control, matched:                                                                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Overall: 45% vs 40% *P* = .52                                                                                                                                                                                                                                                                          | **HR: 113/min (SD 23) vs 98/min (SD 43) *P* = .002** SBP: n/sign                                                | **In‐hospital RBC (mean (SD)): 1414 mL (SD 1660) vs 1007 mL (9351) *P* = .023**                                                                                           | ICU/hospital: n/sign                                                                                                               | n/d                                                                                                                                                                         | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **DBP: 69 mmHg (SD 19) vs 49 mmHg (SD 30) *P* = .003**                                                          |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Rehn M (2018)[35](#tme12659-bib-0035){ref-type="ref"}                                                                                                                                                                                                                                                  | PHTRBC vs control:                                                                                              |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| n/d                                                                                                                                                                                                                                                                                                    | n/d                                                                                                             | Total RBC (pre‐hospital + in‐hospital): 4 (2‐6) vs 6 (4‐12) **Univariate − 0.624 (95% CI −0.717 to −0.531) *P* \< .001**                                                  | n/d                                                                                                                                | n/d                                                                                                                                                                         | PH/IH transfusion reactions: none                                                                                       |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | **Multivariate -- 0.671 (95% CI --0.767 to −0.574) *P* \< .001**                                                                                                          |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Rehn M (2019)[36](#tme12659-bib-0036){ref-type="ref"}                                                                                                                                                                                                                                                  | PHTRBC vs control:                                                                                              |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Overall: 143 (60%) vs 187 (62%)                                                                                                                                                                                                                                                                        | n/d                                                                                                             | 0 (0‐5) vs 7 (4‐12)                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| Univariate: OR 0.90 (95% CI 0.64‐1.28) *P* = .554                                                                                                                                                                                                                                                      |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| Multivariate: OR 0.92 (95% CI 0.64‐1.32) *P* = .648                                                                                                                                                                                                                                                    |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **Prehospital: 66 (28%) vs 126 (42%)**                                                                                                                                                                                                                                                                 |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| ***P* \< .001**                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **Univariate: OR 0.53 (0.36‐0.76) *P* \< .001 Multivariate: OR 0.52 (95% CI 0.35‐0.78) *P* = .001**                                                                                                                                                                                                    |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Sumida MP (2000)[37](#tme12659-bib-0037){ref-type="ref"}                                                                                                                                                                                                                                               | PHTRBC vs control                                                                                               |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| **Overall mortality Frequency ratio: 1.2 vs 1.4 (Live‐1 Die‐2) *P* = .01**                                                                                                                                                                                                                             | Change in mean BP: 5.5 vs 15.6 *P* = .227                                                                       | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | Change in mean HR: 7.6 vs −3.0 *P* = .159                                                                       |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **pH (mean): 7.23 vs 7.37 *P* = .008**                                                                          |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **Bic (mean): 14.6 vs 21.4 *P* = .0001**                                                                        |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Prospective not‐comparative studies                                                                                                                                                                                                                                                                    |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Chang R (2018)[25](#tme12659-bib-0025){ref-type="ref"}                                                                                                                                                                                                                                                 | n/d for PHTRBC                                                                                                  | n/d for PHTRBC                                                                                                                                                            | n/d for PHT                                                                                                                        | n/d for PHTRBC                                                                                                                                                              | CC+ vs CC‐:                                                                                                             | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | CC+ patients had increased mortality at all time points (all *P* \< 0 .001)                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             | Received PHTRBC (n(%)): 18 (44%) vs 82 (8%) *P* \< .001Transfused prehospital plasma: 18 (44%) vs 104 (11%) *P* \< .001 |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Reed M (2017)[24](#tme12659-bib-0024){ref-type="ref"}                                                                                                                                                                                                                                                  | n/d for PHTRBC                                                                                                  | n/d for PHTRBC                                                                                                                                                            | n/d                                                                                                                                | n/d                                                                                                                                                                         | **Coagulopathic patients received more blood component units prehospital (data not provided) *P* \< .01**               | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Sherren PB (2013)[38](#tme12659-bib-0038){ref-type="ref"}                                                                                                                                                                                                                                              | Dead on scene: 22 (15%)                                                                                         | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Transfusion reactions: none                                                                                            |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Weaver AE (2012)[39](#tme12659-bib-0039){ref-type="ref"}                                                                                                                                                                                                                                               | 60d: 52%                                                                                                        | pH (mean): 7.07                                                                                                                                                           | Mean: 10.5                                                                                                                         | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | BE (mean): −12.0                                                                                                                                                          |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Retrospective not‐comparative studies                                                                                                                                                                                                                                                                  |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Berns KS (1998)[40](#tme12659-bib-0040){ref-type="ref"}                                                                                                                                                                                                                                                | Overall: 45% Trauma only: 52%                                                                                   | n/d                                                                                                                                                                       | n/d                                                                                                                                | ICU (mean): 12 Hospital (mean): 22                                                                                                                                          | n/d                                                                                                                     | Complications: none                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Bodnar D‐b (2014)[41](#tme12659-bib-0041){ref-type="ref"}                                                                                                                                                                                                                                              | Trauma only: Dead on scene: 7 (9.9%)                                                                            | n/d                                                                                                                                                                       | Mean (SD): 7.93 (7.18)                                                                                                             | lCU: 5.5 (2,0‐16.25) Hospital: 15.0 (1 .0‐38.5)                                                                                                                             | n/d                                                                                                                     | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | After arrival, in‐hospital: 25 (39%)                                                                            |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Dalton AM (1993)[42](#tme12659-bib-0042){ref-type="ref"}                                                                                                                                                                                                                                               | 24 h: 46 (41%) Overall: 51 (46%)                                                                                | **Volume of blood and change in SBP: *P* = .20**                                                                                                                          | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | PH transfusion reactions: 1 (DIB)                                                                                      |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | MAST vs non‐MAST: SBP rise (mean): 38 mmHg vs 40 mmHg *P* = .29                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Fahy AS (2017)[43](#tme12659-bib-0043){ref-type="ref"}                                                                                                                                                                                                                                                 | Trauma vs non‐trauma                                                                                            |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 30d: 2 (12%) vs 2 (17%) *P* = .39                                                                                                                                                                                                                                                                      | Lactate (mean ± SD): 2.4 ± 0.6 vs 3.2 ± 0.8 *P* = .09                                                           | **In‐hospital RBC (mean \[range\]): 4.3 (0‐8) vs 12.3 (0‐82) *P* = .03**                                                                                                  | Hospital LOS (mean):                                                                                                               | (mean (SD)                                                                                                                                                                  | Hemolysis: none Febrile non‐hemolytic reactions: none                                                                   |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| Overall in‐hospital mortality: 14%                                                                                                                                                                                                                                                                     |                                                                                                                 |                                                                                                                                                                           | 13.4 vs 8.9 *P* = .12                                                                                                              | INR 1.25 ± 0.4 vs 1.3 ± 0.3 *P* = .69 PTT: 29.9 ± 4.5 vs 31.5 ± 9.6 *P* = .58                                                                                               | Anaphylaxis: none                                                                                                       |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | TEG: K 2.8 ± 2.8 vs 2.9 ± 1.1 *P* = .94                                                                                                                                     |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | Angle: 61 ± 15.3 vs 54.5 ± 9.2 *P* = .43                                                                                                                                    |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | R: 4.9 ± 1.7 vs 9.6 ± 9.6 *P* = .04                                                                                                                                         |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | MA: 55 ± 14.7 vs 59.8 ± 4.8 *P* = .55                                                                                                                                       |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | Ly30: 0.75 ± 0.8 vs 0.03 ± 0.05 *P* = .08                                                                                                                                   |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Heschl S (2018)[44](#tme12659-bib-0044){ref-type="ref"}                                                                                                                                                                                                                                                | Trauma only:                                                                                                    | *Changes during treatment*: *arrival at scene ‐ start transfusion ‐ arrival hospital*:                                                                                    | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Complications: none                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | Dead on scene: 13 (9.6%)                                                                                        | **HR: 116 (100‐130) to 119 (103‐132) to 112 (96‐130) *P* \< .001**                                                                                                        |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | After arrival, in‐hospital: 36 (37.7%)                                                                          | **SBP: 90 (80‐110) to 80 (65‐91) to 94 (71‐110) *P* \< .001**                                                                                                             |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | **SI: 1.27 (1.00‐1.57) to 1.50 (1.20‐1.80) to 1.23 (0.98‐1.49) *P* = .004**                                                                                               |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Higgins GL (2012)[45](#tme12659-bib-0045){ref-type="ref"}                                                                                                                                                                                                                                              | Prior to discharge: 31%                                                                                         | Pre‐ vs post‐transfusion:                                                                                                                                                 | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Transfusion reactions: none Complications: none                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | SBP \< 90 mmHg: 71% vs 29% X2 = 9.29 df = 1 *P* = .002                                                                                                                    |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | MAP: 62 mmHg vs 82 mmHg t = −11.090 df = 3 *P* = .002                                                                                                                     |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Hooper N (2017)[46](#tme12659-bib-0046){ref-type="ref"}                                                                                                                                                                                                                                                | Before arrival to hospital: 18%                                                                                 | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Krook C (2018)[47](#tme12659-bib-0047){ref-type="ref"}                                                                                                                                                                                                                                                 | Overall prehospital: 33 (12%)                                                                                   | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | adverse reactions: none                                                                                                |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Krugh D (1994)[48](#tme12659-bib-0048){ref-type="ref"}                                                                                                                                                                                                                                                 | 5 (62.5%)                                                                                                       | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Lyon R (2017)[49](#tme12659-bib-0049){ref-type="ref"}                                                                                                                                                                                                                                                  | Dead on scene: 38 (26%)                                                                                         | Mean (range) ± SD                                                                                                                                                         | n/d                                                                                                                                | ICU: 6 (2‐17) Hospital: 18 (3‐32)                                                                                                                                           | n/d                                                                                                                     | Complications: none Ionized calcium (mean): 1.1 mmol/L; **Lower with increasing volume of PRBCs transfused *P* = .03** |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | After arrival to hospital:                                                                                      | pH: 7.15 (6.60‐7.42) ± 0.17                                                                                                                                               |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | 6 h: 16% 28‐d: 30%                                                                                              | BE(mEq/L): −9.48 (−28.20‐0.40) ± 6.82                                                                                                                                     |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | Lactate(mmol/L): 5.27 (0.90‐19.90) ±4.08                                                                                                                                  |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | **Changes during treatment: before transfusion vs at arrival to hospital:**                                                                                               |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | **SBP increased *P* \< .001**                                                                                                                                             |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | **DBP increased *P* \< .001**                                                                                                                                             |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | **MAP increased *P* \< .001**                                                                                                                                             |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | HR: *P* = .96 (data not provided)                                                                                                                                         |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Maher P (2017)[50](#tme12659-bib-0050){ref-type="ref"}                                                                                                                                                                                                                                                 | PHTRBC: 5 (38%) PHT‐plasma: 1 (33%) Scene transports: 2 (22%)                                                   | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | Interfacility transports: 4 (57%)                                                                               |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Mena‐Munoz J (2016)[51](#tme12659-bib-0051){ref-type="ref"}                                                                                                                                                                                                                                            | In‐hospital 30d:                                                                                                | Overall:                                                                                                                                                                  | Odds of in‐hospital transfusion after PHTRBC:                                                                                      | Overall:                                                                                                                                                                    | Overall:                                                                                                                | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | Overall: 22.5% (CI 20.4%‐25.0%)                                                                                 | Lactate 2.4 (1.4‐4.8)                                                                                                                                                     | OR = 2.00 (95% CI 1.46‐2.76)                                                                                                       | Hospital: 7 (3‐14)                                                                                                                                                          | PTT: 32.1 (27.3‐38.6)                                                                                                   |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | *PHTRBC vs no‐PHTRBC*: 201 (28%) vs 252 (27%) OR 0.77 (0.53‐1.13)                                               |                                                                                                                                                                           |                                                                                                                                    | ICU: 4 (1‐9)                                                                                                                                                                | INR: 1.4 (1.2‐1.8)                                                                                                      |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **Transfused \> 700 mL vs \< 350 mL: 48 (47%) vs 161 (23%) OR = 2.11 (95% CI 1.21‐3.69)**                       |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Mix FM (2018)[52](#tme12659-bib-0052){ref-type="ref"}                                                                                                                                                                                                                                                  | n/d                                                                                                             | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Potter D (2015)[53](#tme12659-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                | Prior to discharge: 4 (25%)                                                                                     | Mean (range)                                                                                                                                                              | Mean 3.6 (range 0‐13)                                                                                                              | Hospital: mean 9.3 (range 1‐45)                                                                                                                                             | *Overall vs PHT‐plasma+RBC vs PHTRBC*:                                                                                  | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | Arrival Lactate: 3.6 mg/dL (1.1‐7.1)                                                                                                                                      |                                                                                                                                    |                                                                                                                                                                             | INR arrival (mean (range)): 1.4 (0.9‐2.7) vs 1.2 (0.9‐1.4) vs 1.5 (1.1‐2.7) (no analysis)                               |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | Arrival BE: −5.7 (−14.0 ‐ ‐4.0) Difference BE in‐transport vs arrival: unchanged in n = 3, improved in n = 2 (−8.0 to −6.0 after 3 U RBC and − 7.0 to −3.0 after 2 U RBC) |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Raitt JE (2018)[54](#tme12659-bib-0054){ref-type="ref"}                                                                                                                                                                                                                                                | On scene: 9 (14%) In ED 8 (14%) In‐hospital 11 (19%) 15 (26.3%)                                                 | n/d                                                                                                                                                                       | 5 (range 1‐29)                                                                                                                     | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Sunde GA (2015)[55](#tme12659-bib-0055){ref-type="ref"}                                                                                                                                                                                                                                                | On scene: 2 (50%)                                                                                               | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Transfusion reactions: none                                                                                            |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | After arrival, prior to discharge: 0                                                                            |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         | Complications: none                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Thiels CA (2016)[56](#tme12659-bib-0056){ref-type="ref"}                                                                                                                                                                                                                                               | *Overall*: 30d: 18.0%                                                                                           | *Overall*:                                                                                                                                                                | In‐hospital RBC (mean ± SD):                                                                                                       | Hospital LOS (mean ± SD):                                                                                                                                                   | *Non‐trauma vs Trauma (mean ± SD)*: INR: 1.6 ± 0.8 vs 1.5 ± 1.0 *P* = .14                                               | Minor allergic reaction after additional in‐hospital plasma: 1 (0.1%)                                                  |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | *Non‐trauma vs trauma*:                                                                                         | Hemodynamically unstable on admission: 124 (64%)                                                                                                                          | *Non‐trauma vs trauma*: 7.1 ± 8.7 vs 8.2 ± 10.8 *P* = .19                                                                          | *Non‐trauma vs Trauma*: **9.4 ± 11.2 vs 12.2 ± 19.1 *P* = .009** *Surgical vs Medical vs GI‐bleed*: **12.1 ± 13.9 vs 9.5 ± 11.5 vs 6.3 ± 5.4 *P* \< .001**                  | **PTT: 34.4 ± 13.5 vs 33.2 ± 13.7 *P* = .06**                                                                           | Volume overload: none TRALI: none                                                                                      |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **1d: 5% vs 10% *P* = .002**                                                                                    | *Non‐trauma vs trauma*                                                                                                                                                    | *Surgical vs Medical vs G‐I bleed*: 7.4 ± 8.3 vs 8.2 ± 11.6 vs 6.1 ± 6.9 *P* = .51                                                 |                                                                                                                                                                             | **TEG R‐time (min): 8.2 ± 6.6 vs 5.7 ± 3.1 *P* \< .001**                                                                | Hemolytic transfusion reaction: none                                                                                   |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **30d: 16% vs 22% *P* = .03**                                                                                   | **Lactate (mean ± SD): 3.2 ± 3.4 vs 3.3 ± 2.7 *P* = .003**                                                                                                                |                                                                                                                                    |                                                                                                                                                                             | **A‐angle: 60.8 ± 15.1 vs 65.1 ± 9.7 *P* = .03**                                                                        |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | *Surgical vs Medical vs GI‐bleed*:                                                                              |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             | MA (mm): 60.0 ± 14.5 vs 61.9 ± 9.6 *P* = .61                                                                            |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **1d: 6% vs 6% vs 2% *P* = .045**                                                                               |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             | LYS30(%): 2.2 ± 8.5 vs 1.4 ± 2.9 *P* = .19                                                                              |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | 30d: 15% vs 21% vs 13% *P* = .12                                                                                |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Wheeler R (2013)[23](#tme12659-bib-0023){ref-type="ref"}                                                                                                                                                                                                                                               | n/d                                                                                                             | n/d                                                                                                                                                                       | n/d                                                                                                                                | Hypothermic vs non‐hypothermic (mean ± SD):                                                                                                                                 | n/d                                                                                                                     | **PHTRBC vs controls: hypothermia OR 6.27 (95% CI 2.47‐14.89) *P* \< .05**                                             |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | ICU: 8.96 ± 8.72 vs 7.10 ± 8.51                                                                                                                                             |                                                                                                                         | **PHTRBC in Oct‐Dec: OR 13.50 (85% CI 1.49‐165.25)**                                                                   |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | Hospital: 18.20 ± 23.81 vs 8.67 ± 12.82                                                                                                                                     |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Case reports                                                                                                                                                                                                                                                                                           |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Garner AA (1999)[57](#tme12659-bib-0057){ref-type="ref"}                                                                                                                                                                                                                                               | *n* = 1, survived                                                                                               | n/d                                                                                                                                                                       | 56 (*n* = 1)                                                                                                                       | ICU: 88 (*n* = 1)                                                                                                                                                           | n/d                                                                                                                     | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Lawton LD (2012)[58](#tme12659-bib-0058){ref-type="ref"}                                                                                                                                                                                                                                               | *n* = 1, survived until ICU admission                                                                           | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Macnab AJ (1996)[59](#tme12659-bib-0059){ref-type="ref"}                                                                                                                                                                                                                                               | *n* = 1, survived until hospital admission                                                                      | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Hemolysis of donor red cell units during transit: 2 incidents because of improper packaging or cooling                 |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Description of protocol                                                                                                                                                                                                                                                                                |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Trembley AL (2016)[60](#tme12659-bib-0060){ref-type="ref"}                                                                                                                                                                                                                                             | n/d                                                                                                             | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Adverse effects: none                                                                                                  |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Vartanian, L (2017)[61](#tme12659-bib-0061){ref-type="ref"}                                                                                                                                                                                                                                            | Before hospital arrival: 1 (8%)                                                                                 | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Military services                                                                                                                                                                                                                                                                                      |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Prospective comparative studies                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Vitalis V (2017)[62](#tme12659-bib-0062){ref-type="ref"}                                                                                                                                                                                                                                               | PHT vs control:                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| 24 h: 2 (28.6%) vs 3 (14%) (no analysis performed)                                                                                                                                                                                                                                                     | n/d                                                                                                             | Total in‐hospital RBC:                                                                                                                                                    | n/d                                                                                                                                | n/d                                                                                                                                                                         | Complications: none                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | 1 (0.25‐5.5) vs 0 (0‐2) *P* = .05                                                                                                                                         |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Retrospective comparative studies                                                                                                                                                                                                                                                                      |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Howard, JT (2017)[63](#tme12659-bib-0063){ref-type="ref"}                                                                                                                                                                                                                                              | Needed & received PHT vs needed but no PHT:                                                                     |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| KIA: AOR 0.17 (95% CI 0.06‐0.51, *P* = .002)                                                                                                                                                                                                                                                           | n/d                                                                                                             | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| O\'Reilly DJ‐b (2014)[64](#tme12659-bib-0064){ref-type="ref"}                                                                                                                                                                                                                                          | PHT vs control, matched:                                                                                        |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| **30d: 8 (8.2%) vs 19 (19.6%) *P* = .013**                                                                                                                                                                                                                                                             | SBP: 132 (111‐145) vs 131 (114‐150) *P* = .145                                                                  | **In‐hospital RBC: 2 (1‐8.5) \[0‐49\] vs 0 (0‐3.5) \[0‐26\] *P* \< .001**                                                                                                 | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | **HR: 92 (74‐115) vs 105 (82‐128) *P* = .041**                                                                  | **Total RBC: 4 (2‐10) \[0‐53\] vs 0 (0‐3.5) \[0‐26\] *P* \< .001**                                                                                                        |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Shackelford S (2017)[65](#tme12659-bib-0065){ref-type="ref"}                                                                                                                                                                                                                                           | PHT vs control, matched:                                                                                        |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| **24 h: 3 (5%) vs 69 (20%) (between‐group difference − 15% (95% CI − 22% ‐ − 7%) *P* = .007 AHR 0.26 (95% CI 0.08‐0.84) *P* = .02**                                                                                                                                                                    | pH: 7.28 (7.17‐7.38) vs 7.29 (7.24‐7.34) *P* = .65                                                              | **24 h RBC/WB: 15 (8‐23) vs 11 (8.5‐13.5) *P* = .002**                                                                                                                    | Hospital: 30 (21‐30) vs 30 (27‐33) *P* \> .99                                                                                      | **INR: 1.40 (1.2‐1.7) vs 1.26 (1.16‐1.36) *P* = .008**                                                                                                                      | n/d                                                                                                                     |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **30d: 6 (11%) vs 78 (23%) (between‐group difference − 12% (95% CI − 21% ‐ − 2%) *P* = .05 AHR 0.39 (95% CI 0.16‐0.92) *P* = .03**                                                                                                                                                                     | BE: −7 (−11 ‐ −4) vs −6.2 (−7.9 ‐ −4.4) *P* = .37                                                               |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| 30d mortality in 24 h survivors: 3 (6%) vs 9 (3%) AHR 0.84 (95% CI 0.18‐4.00) *P* = .83 *Time to first transfusion and 24 h mortality*: **Time to transfusion \< 15 min of MEDEVAC rescue (median 36 min after injury) vs delayed treatment: 2(3%) vs 68 (21%) AHR 0.17 (95% CI 0.04‐0.73) *P* = .02** | Shock on arrival: 42 (76%) vs 206 (69%)                                                                         |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| **After sensitivity analysis allowing for transfusion futility: 2 (3%) vs 47 (16%) AHR 0.23 (95% CI 0.06‐0.96) *P* = .04**                                                                                                                                                                             | Adjusted for risk of prehospital death: AOR 1.01 (95% CI 0.86‐1.18) *P* = .94                                   |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
| Time to transfusion 16 to 20 min after MEDEVAC vs delayed treatment: 10 (33%) vs 46 (17%) AHR 0.94 (95% CI 0.41‐2.17) *P* = .89                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Prospective not‐comparative studies                                                                                                                                                                                                                                                                    |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Aye Maung N (2015)[66](#tme12659-bib-0066){ref-type="ref"}                                                                                                                                                                                                                                             | Overall: 0% (*n* = 2)                                                                                           | Changes during treatment: radial pulse returned (*n* = 2)                                                                                                                 | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Adverse events: none                                                                                                   |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         | Out‐of‐standard blood product temperature: 7 incidents                                                                 |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Malsby RF (2013)[67](#tme12659-bib-0067){ref-type="ref"}                                                                                                                                                                                                                                               | 24 h: 2 (33%, *n* = 6))                                                                                         | BE (*n* = 5): −7 (−7 ‐ ‐4)                                                                                                                                                | 10 (3.5‐14.5) (*n* = 7)                                                                                                            | n/d                                                                                                                                                                         | n/d                                                                                                                     | Adverse reactions: none                                                                                                |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | Pre‐ vs post‐transfusion:                                                                                                                                                 |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         | Out‐of‐standard blood product temperature: none                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | SBP 99 (80‐116) vs 120 (104‐134)                                                                                                                                          |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | HR 132 (128‐138) vs 123 (112‐138)                                                                                                                                         |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Retrospective not‐comparative studies                                                                                                                                                                                                                                                                  |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Barkana Y (1999)[68](#tme12659-bib-0068){ref-type="ref"}                                                                                                                                                                                                                                               | In‐hospital: 16%                                                                                                | SBP on arrival: 110                                                                                                                                                       | "Emergency phase RBC": 5 (0‐4)                                                                                                     | n/d                                                                                                                                                                         | n/d                                                                                                                     | Adverse reaction:                                                                                                      |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         | 1 (rash)                                                                                                               |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Chen J (2017)[69](#tme12659-bib-0069){ref-type="ref"}                                                                                                                                                                                                                                                  | Overall: 10 (11%)                                                                                               | Scene vs hospital arrival: SBP: 119 (90‐130) vs 120 (80‐130) *P* = .49                                                                                                    | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Adverse reactions: none                                                                                                |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | On arrival to hospital: 7 (8%)                                                                                  | DBP: 70 (60‐80) vs 70 (60‐80)*P* = .23                                                                                                                                    |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         | Immediate transfusion‐related complications: none                                                                      |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | 24 h: 9 (10%)                                                                                                   | **HR: 119 (100‐130) vs 108 (90‐120) *P* \< .01**                                                                                                                          |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         | Technical problems: none                                                                                               |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | In‐hospital: 3 (3%)                                                                                             | SI: 1 (0.78‐1.24) vs 0.94 (0.73‐1.5) *P* = .89                                                                                                                            |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Edgar IA (2014)[70](#tme12659-bib-0070){ref-type="ref"}                                                                                                                                                                                                                                                | After arrival, in‐hospital: 4.5% (n/s for PHTRBC)                                                               | MERT vs PEDRO:                                                                                                                                                            | MERT vs PEDRO:                                                                                                                     | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | SBP: 130 (61‐170) vs 75 (46‐108) *P* = .0849                                                                                                                              | RBC in ED: 5 (2‐14) vs 12 (6‐21) (no analysis)                                                                                     |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | HR: 112 (80‐152) vs 89 (62‐150) *P* = .3629                                                                                                                               | **Correlation between use of increased volumes of PHT and reduced total transfusion requirement *P* \< .0194 (data not provided**) |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | pH: 7.26 (6.9‐7.5) vs 7.27 (7.22‐7.32) (no analysis)                                                                                                                      |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | **Increased volumes of PHT and SBP closer to physiological normal at arrival to role 3 *P* = .0296 (data not provided)**                                                  |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Morrison JJ (2013)[71](#tme12659-bib-0071){ref-type="ref"}                                                                                                                                                                                                                                             | *AMR vs CMR*:                                                                                                   | n/d                                                                                                                                                                       | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | n/d                                                                                                                    |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | overall: 9.1% vs 9.2% *P* = .536 (n/s for PHTRBC)                                                               |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| O\'Reilly DJ‐a (2014)[72](#tme12659-bib-0072){ref-type="ref"}                                                                                                                                                                                                                                          | Overall: 62 (20%)                                                                                               | n/d                                                                                                                                                                       | 7 (1‐15) total RBC: 8 (3‐18)                                                                                                       | n/d                                                                                                                                                                         | n/d                                                                                                                     | Adverse effects: none                                                                                                  |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         | Complications: none                                                                                                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Powell‐Dunford N (2014)[73](#tme12659-bib-0073){ref-type="ref"}                                                                                                                                                                                                                                        | 24 h: 8 (13%)                                                                                                   | BE: −9 (−14 ‐ −6)                                                                                                                                                         | 10 (8‐14)                                                                                                                          | n/d                                                                                                                                                                         | INR: 1.2 (1.1‐1.4)                                                                                                      | Adverse reaction: none                                                                                                 |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | *Pre‐ vs post‐transfusion*:                                                                                                                                               |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | SBP: 86 (70‐104) vs 108 (85‐127) *P* = .001                                                                                                                               |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | DBP: 52 (40‐66) vs 60 (47‐71)                                                                                                                                             |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | HR: 133 (125‐141) vs 125 (110‐138) *P* = .000                                                                                                                             |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | SI: 1.6 (1.2‐2.0) vs 1.1 (1.0‐1.5) *P* \< .01                                                                                                                             |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 | MSI: 2.2 (1.7‐2.6) vs 1.7 (1.3‐2.1) *P* = .000                                                                                                                            |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Shlaifer A (2017)[74](#tme12659-bib-0074){ref-type="ref"}                                                                                                                                                                                                                                              | In‐hospital: 11 (12%)                                                                                           | n/d                                                                                                                                                                       | n/d                                                                                                                                | ICU:                                                                                                                                                                        | n/d                                                                                                                     | Adverse event to FDP: 1 (chills and shivering)                                                                         |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        | (n/s for PHTRBC)                                                                                                |                                                                                                                                                                           |                                                                                                                                    | 1‐3d: 19(35%) 4‐6d: 12(22%) 7‐13:13(24%) 14d+: 10(19%)                                                                                                                      |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | Hospital:                                                                                                                                                                   |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | ≤6d: 24(26%)                                                                                                                                                                |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | 7‐13d: 24(26%) 14‐20d: 10(11%) 21d+: 34(37%)                                                                                                                                |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
|                                                                                                                                                                                                                                                                                                        |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    | (n/s for PHTRBC)                                                                                                                                                            |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| Case reports                                                                                                                                                                                                                                                                                           |                                                                                                                 |                                                                                                                                                                           |                                                                                                                                    |                                                                                                                                                                             |                                                                                                                         |                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+
| West BC (2004)[75](#tme12659-bib-0075){ref-type="ref"}                                                                                                                                                                                                                                                 | *n* = 1, survived to facility                                                                                   | SBP improved from unobtainable to 100 (*n* = 1)                                                                                                                           | n/d                                                                                                                                | n/d                                                                                                                                                                         | n/d                                                                                                                     | Adverse reactions: none                                                                                                |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+

In bold values represents statistically significant results.

*Note*: Values presented as median (IQR) unless otherwise specified. Available *P*‐values have been presented. Boldface indicates significant outcomes.

Abbreviations: ACT, activated clotting time; (A)HR: (Adjusted) Hazard Ratio AMR: Advanced Medical Retrieval (A)OR: (Adjusted) Odds Ratio aPTT, activated partial thromboplastin time; ARDS, Acute Respiratory Distress Syndrome ARF, acute renal failure BE, Base excess Bic, bicarbonate; CC, clinically evident coagulopathic bleeding; CI, Confidence Interval CMR, Conventional Military Retrieval DBP, diastolic blood pressure DIB, difficulty in breathing DOW, Died of Wounds (died after arrival to facility) (F)WB, (Fresh) Whole Blood GI, gastro‐intestinal HR, Heart Rate ICU, intensive care unit IH, in‐hospital INR, International Normalized Ratio IQR, Interquartile Range KIA, Killed in action (died before arrival to facility) LOS, length of stay MAP, Mean arterial pressure MAST, medical antishock trousers MERT, Medical Emergency Response Team MSI, Modified shock index (heart rate/mean blood pressure); n/d, not described n/s, not specified n/sign, not significant PH, prehospital PHT, prehospital transfusion PHT‐plasma, prehospital transfusion of plasma; PHTRBC, Prehospital Transfusion of Red Blood Cells RBC, Red blood cells SBP, Systolic Blood Pressure SI, Shock Index TEG, Thromboelastography TIC, trauma induced coagulopathy TRALI, Transfusion related lung injury; U, units.

Values at arrival to hospital, unless otherwise specified.

A positive INR Change denotes an improvement in coagulopathy.

### 3.3.2. Military {#tme12659-sec-0011}

In military services, almost all studies included patients who possibly received other prehospital blood products besides RBC. Two retrospective studies compared trauma PHT recipients to non‐receivers, and found significantly lower mortality in PHT patients (either overall, 24 hours or 30‐day mortality) (Table [5](#tme12659-tbl-0005){ref-type="table"}).[65](#tme12659-bib-0065){ref-type="ref"}, [72](#tme12659-bib-0072){ref-type="ref"} One of these studies subsequently focused on those patients who survived the first 24 hours; the beneficial effect on 30‐day mortality was no longer present.[65](#tme12659-bib-0065){ref-type="ref"} This concurs with a large retrospective study (with a partially overlapping study population), where the odds for "killed in action" (KIA) mortality (death before arrival at treatment facility) was 83% lower for casualties who needed and received prehospital transfusion, compared with patients who needed but did not receive a prehospital transfusion.[63](#tme12659-bib-0063){ref-type="ref"}

3.4. *Outcome---Shock after transfusion* {#tme12659-sec-0012}
----------------------------------------

### 3.4.1. Civilian {#tme12659-sec-0013}

Six observational studies compared vital parameters or POCT results before and after transfusion.[32](#tme12659-bib-0032){ref-type="ref"}, [42](#tme12659-bib-0042){ref-type="ref"}, [44](#tme12659-bib-0044){ref-type="ref"}, [45](#tme12659-bib-0045){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"}, [53](#tme12659-bib-0053){ref-type="ref"} Five of these noted significant beneficial effects of PHTRBC (decrease in heart rate \[HR\] and shock index \[SI\],[44](#tme12659-bib-0044){ref-type="ref"} rise in systolic,[44](#tme12659-bib-0044){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"} diastolic[49](#tme12659-bib-0049){ref-type="ref"} or mean arterial blood pressures,[45](#tme12659-bib-0045){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"} less hypotensive episodes (ie, SBP \< 90 mmHg)[45](#tme12659-bib-0045){ref-type="ref"} or less "haemodynamic instability"[32](#tme12659-bib-0032){ref-type="ref"}) (Table [5](#tme12659-tbl-0005){ref-type="table"}).

Studies comparing vital parameters in PHTRBC patients vs non‐receivers report conflicting results: significantly lower occurrence of hypotension,[28](#tme12659-bib-0028){ref-type="ref"} a higher DBP,[34](#tme12659-bib-0034){ref-type="ref"} and a higher BE and pH[18](#tme12659-bib-0018){ref-type="ref"} have been reported in PHTRBC patients, but in contrast, significantly lower SBP,[26](#tme12659-bib-0026){ref-type="ref"}, [29](#tme12659-bib-0029){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"} a higher HR,[34](#tme12659-bib-0034){ref-type="ref"} a lower pH[26](#tme12659-bib-0026){ref-type="ref"}, [37](#tme12659-bib-0037){ref-type="ref"} and a lower bicarbonate level[37](#tme12659-bib-0037){ref-type="ref"} have also been found. Other studies found no significant differences in either SBP,[18](#tme12659-bib-0018){ref-type="ref"}, [34](#tme12659-bib-0034){ref-type="ref"} DBP,[26](#tme12659-bib-0026){ref-type="ref"} HR,[18](#tme12659-bib-0018){ref-type="ref"}, [26](#tme12659-bib-0026){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"} BE,[26](#tme12659-bib-0026){ref-type="ref"}, [28](#tme12659-bib-0028){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"} lactate,[33](#tme12659-bib-0033){ref-type="ref"} change in mean BP or in HR[37](#tme12659-bib-0037){ref-type="ref"} or occurrence of "shock on admission."[33](#tme12659-bib-0033){ref-type="ref"} Kim et al[22](#tme12659-bib-0022){ref-type="ref"} compared PHTRBC with PHTRBC + PHT‐plasma and found no significant differences in SBP, HR, lactate, BE or pH. Brown et al[29](#tme12659-bib-0029){ref-type="ref"} measured base deficit and lactate levels on arrival to hospital, and used these to calculate the odds of shock. They found that in PHTRBC patients, these odds were significantly lower than in matched control patients (Table [5](#tme12659-tbl-0005){ref-type="table"}).

### 3.4.2. Military {#tme12659-sec-0014}

In military EMS, three observational studies analysed the change in vital parameters after transfusion, all showing improvements (significant rise in SBP and improvement in SI[73](#tme12659-bib-0073){ref-type="ref"}; a fall in HR[69](#tme12659-bib-0069){ref-type="ref"}, [73](#tme12659-bib-0073){ref-type="ref"}; or a SBP closer to physiologically normal values as the prehospital transfused volume increased[70](#tme12659-bib-0070){ref-type="ref"}).

Only one study comparing PHTRBC patients to controls found a significant difference reporting a lower HR.[72](#tme12659-bib-0072){ref-type="ref"} No significant differences were found for SBP, pH, BE, or "shock on arrival"[65](#tme12659-bib-0065){ref-type="ref"}, [72](#tme12659-bib-0072){ref-type="ref"} (Table [5](#tme12659-tbl-0005){ref-type="table"}).

3.5. *Outcome---24‐hour RBC Requirement* {#tme12659-sec-0015}
----------------------------------------

### 3.5.1. Civilian {#tme12659-sec-0016}

In the first 24 hours after admission to hospital, civilian patients received a median of 0 to 14 U of RBC,[22](#tme12659-bib-0022){ref-type="ref"}, [26](#tme12659-bib-0026){ref-type="ref"}, [28](#tme12659-bib-0028){ref-type="ref"}, [29](#tme12659-bib-0029){ref-type="ref"}, [30](#tme12659-bib-0030){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"}, [36](#tme12659-bib-0036){ref-type="ref"}, [39](#tme12659-bib-0039){ref-type="ref"}, [41](#tme12659-bib-0041){ref-type="ref"}, [54](#tme12659-bib-0054){ref-type="ref"} and paediatric patients received a mean of 3.6 U.[53](#tme12659-bib-0053){ref-type="ref"}

Five analyses found the RBC requirement in‐hospital or in the first 24 hours to be significantly higher for PHTRBC patients,[26](#tme12659-bib-0026){ref-type="ref"}, [28](#tme12659-bib-0028){ref-type="ref"}, [31](#tme12659-bib-0031){ref-type="ref"}, [34](#tme12659-bib-0034){ref-type="ref"}, [43](#tme12659-bib-0043){ref-type="ref"} whereas five others found it to be significantly lower.[18](#tme12659-bib-0018){ref-type="ref"}, [29](#tme12659-bib-0029){ref-type="ref"}, [30](#tme12659-bib-0030){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"}, [35](#tme12659-bib-0035){ref-type="ref"} One of these studies noted that taking the prehospital transfused volume into account, the cumulative 24 hours RBC requirement was not significantly different.[33](#tme12659-bib-0033){ref-type="ref"} Two other studies found no significant difference in in‐hospital or 24 hours RBC requirement in either PHT vs control or in PHTRBC vs PHTRBC+PHT plasma[22](#tme12659-bib-0022){ref-type="ref"}, [32](#tme12659-bib-0032){ref-type="ref"} (Table [5](#tme12659-tbl-0005){ref-type="table"}).

### 3.5.2. Military {#tme12659-sec-0017}

Median RBC requirement in the first 24 hours after arrival to hospital was 5 to 10 units,[67](#tme12659-bib-0067){ref-type="ref"}, [68](#tme12659-bib-0068){ref-type="ref"}, [73](#tme12659-bib-0073){ref-type="ref"} one study reporting a median of 15 units of RBC/fresh whole blood in 24 hours.[65](#tme12659-bib-0065){ref-type="ref"} One study focusing on double amputees showed that an increased volume of prehospital transfused blood was significantly associated with a decreased transfusion requirement in the emergency department.[70](#tme12659-bib-0070){ref-type="ref"} However, three comparative studies observed (an almost) significantly higher 24 hours or in‐hospital transfusion requirement in PHTRBC patients.[62](#tme12659-bib-0062){ref-type="ref"}, [65](#tme12659-bib-0065){ref-type="ref"}, [72](#tme12659-bib-0072){ref-type="ref"}

3.6. *Outcome---Signs of trauma‐induced coagulopathy (TIC) on arrival to hospital* {#tme12659-sec-0018}
----------------------------------------------------------------------------------

Three civilian studies compared the international normalised ratio (INR) of patients who received PHTRBC vs patients who did not. One study reported that PHTRBC patients had significantly lower odds of TIC [28](#tme12659-bib-0028){ref-type="ref"} on arrival to hospital, while two other studies did not find an association between PHTRBC and INR.[29](#tme12659-bib-0029){ref-type="ref"}, [33](#tme12659-bib-0033){ref-type="ref"} One study reported that coagulopathic patients had received significantly more units of PHTRBC than non‐coagulopathic patients.[24](#tme12659-bib-0024){ref-type="ref"} All the other studies reporting on coagulation state are biased by the use of prehospital plasma besides the PHTRBC[18](#tme12659-bib-0018){ref-type="ref"}, [22](#tme12659-bib-0022){ref-type="ref"}, [25](#tme12659-bib-0025){ref-type="ref"}, [26](#tme12659-bib-0026){ref-type="ref"}, [32](#tme12659-bib-0032){ref-type="ref"}, [43](#tme12659-bib-0043){ref-type="ref"}, [56](#tme12659-bib-0056){ref-type="ref"}, [65](#tme12659-bib-0065){ref-type="ref"} (Table [5](#tme12659-tbl-0005){ref-type="table"}).

3.7. *Outcome---Length of stay in ICU/in hospital* {#tme12659-sec-0019}
--------------------------------------------------

Three civilian studies compared length of stay (LOS) in ICU and LOS in hospitals for PHTRBC patients and their matched controls. No significant differences were found.[22](#tme12659-bib-0022){ref-type="ref"}, [32](#tme12659-bib-0032){ref-type="ref"}, [34](#tme12659-bib-0034){ref-type="ref"}

Only one military study describes LOS, finding a median hospital LOS of 30 days for both PHTRBC patients and controls.[65](#tme12659-bib-0065){ref-type="ref"}

3.8. *Outcome---Safety/adverse events* {#tme12659-sec-0020}
--------------------------------------

Most studies on civilian EMS (11) reported no transfusion reactions occurring.[30](#tme12659-bib-0030){ref-type="ref"}, [35](#tme12659-bib-0035){ref-type="ref"}, [38](#tme12659-bib-0038){ref-type="ref"}, [40](#tme12659-bib-0040){ref-type="ref"}, [43](#tme12659-bib-0043){ref-type="ref"}, [44](#tme12659-bib-0044){ref-type="ref"}, [45](#tme12659-bib-0045){ref-type="ref"}, [47](#tme12659-bib-0047){ref-type="ref"}, [49](#tme12659-bib-0049){ref-type="ref"}, [55](#tme12659-bib-0055){ref-type="ref"}, [60](#tme12659-bib-0060){ref-type="ref"} A lung injury associated with a transfusion was reported,[32](#tme12659-bib-0032){ref-type="ref"} and there was one possible adverse reaction in a trauma patient who developed shortness of breath, which was interpreted as secondary to volume overload.[42](#tme12659-bib-0042){ref-type="ref"} A case report has described two "near miss" incidents where haemolysis of donor cells occurred during transport, when the units had not been packed correctly.[59](#tme12659-bib-0059){ref-type="ref"}

Patients transfused before arrival to hospital were more likely to be hypothermic[23](#tme12659-bib-0023){ref-type="ref"} and have lower calcium levels,[49](#tme12659-bib-0049){ref-type="ref"} but there was no significant difference in the occurrence of acute respiratory distress syndrome (ARDS) in PHTRBC, non‐PHTRBC and PHTRBC+PHT‐plasma patients.[22](#tme12659-bib-0022){ref-type="ref"}, [29](#tme12659-bib-0029){ref-type="ref"}

As in civilian services, seven military studies have reported no adverse reactions to PHTRBC.[62](#tme12659-bib-0062){ref-type="ref"}, [64](#tme12659-bib-0064){ref-type="ref"}, [66](#tme12659-bib-0066){ref-type="ref"}, [67](#tme12659-bib-0067){ref-type="ref"}, [69](#tme12659-bib-0069){ref-type="ref"}, [74](#tme12659-bib-0074){ref-type="ref"}, [75](#tme12659-bib-0075){ref-type="ref"} One possible transfusion reaction is described, in which a patient developed a fine rash on their trunk after one unit of RBC.[68](#tme12659-bib-0068){ref-type="ref"} Seven incidents were reported where the blood products were found to have an out‐of‐standard temperature.[66](#tme12659-bib-0066){ref-type="ref"}

4. DISCUSSION {#tme12659-sec-0021}
=============

This systematic review summarises the literature regarding the effects of PHTRBC on several outcome measures.

Overall, evidence of an effect of PHTRBC on outcomes is of limited quality. Notably, no controlled studies were identified, and all studies were observational. Therefore, all reported treatment effects must be interpreted with care. Confounding is likely---and residual confounding cannot be excluded in those studies that attempted to control for confounding---such that causal inferences on the effect of PHTRBC on outcomes are essentially not possible.[77](#tme12659-bib-0077){ref-type="ref"} Nonetheless, in the absence of controlled trials, these studies represent the best available evidence and may at least provide some insight about possible associations between PHTRBC and outcomes.

The high heterogeneity of the studies was a second factor, which impedes the interpretation of the reported data. As we had expected, patients transported by civilian and military services differed considerably with respect to injury type, injury severity and mortality rates. However, also within these groups, heterogeneity in injury type, injury severity, type of transport, transfusion criteria and type of intervention prevented meaningful meta‐analysis. Differences between study outcomes might at least in part be explained by these factors.

4.1. *Mortality* {#tme12659-sec-0022}
----------------

Results on overall mortality are conflicting, and we found no consistent evidence for any effects of PHTRBC on survival. Recently, Rijnhout et al[78](#tme12659-bib-0078){ref-type="ref"} published a meta‐analysis on the effects of prehospital transfusion on mortality. In line with our results, these authors did not observe an effect of PHTRBC (without simultaneous transfusion of plasma) on mortality. For the 24 hours mortality, an odds ratio of 0.92 was reported, with a broad 95% confidence interval (0.46‐1.85) that does not exclude clinically important effects of PHTRBC in either direction, which indicates an inconclusive result.[79](#tme12659-bib-0079){ref-type="ref"} Importantly, heterogeneity was high (I^2^ 80%), similar to the heterogeneity that we observed in explorative analyses. While quantitative heterogeneity was lower for long‐term survival, qualitative heterogeneity, along with limited quality and a substantial potential for residual confounding in the observational studies, prompted us to question whether it was appropriate to report a pooled effect estimate. Nonetheless, despite these limitations, the data by Rijnhout et al can be considered hypothesis generating and do suggest that the combination of PHTRBC and plasma may potentially be beneficial for long‐term survival, warranting further investigation. Similarly, a recent systematic review by Shand et al reported high heterogeneity and the authors could not draw conclusions about the effect of prehospital transfusion of any blood component on outcome.[80](#tme12659-bib-0080){ref-type="ref"} Previous systematic reviews have summarised the evidence up to 2015[81](#tme12659-bib-0081){ref-type="ref"} and 2016,[82](#tme12659-bib-0082){ref-type="ref"} however, numerous studies have been published thereafter such that a more up to date systematic review is warranted.

4.2. *Haemodynamics, coagulopathy, 24‐hours RBC requirement and LOH/ICU stay* {#tme12659-sec-0023}
-----------------------------------------------------------------------------

Observational studies in both civilian and military services found that after PHTRBC, SBP recovers, HR decreases and SI improves. However, these improvements could be due to the administration of analgesia or fluids in general or merely be time‐dependent effects. Outcomes of comparative studies in both military and civilian services reporting on haemodynamics, coagulopathy or 24‐hour RBC requirement are conflicting and could not confirm an effect of PHTRBC on any of these variables.

A large majority of patients in both civilian and military observational studies required transfusion after arrival to hospital, which may be seen as confirmation of the appropriateness of prehospital transfusions. Some studies reported a higher 24 hours RBC requirement in PHTRBC patients, while others reported this to be lower. A higher 24 hours RBC requirement may suggest that the patients who were bleeding most severely had been identified correctly in the prehospital setting as requiring PHTRBC. These patients, in turn, also have a higher demand for blood products when at the hospital. An explanation of a lower 24 hours RBC requirement in PHTRBC patients could be that these patients bled less through prevention of coagulopathy and thus required less transfusion. However, there is thus far no evidence that PHTRBC generally reduces the occurrence of TIC. In some cases, the PHTRBC patients may merely have received the blood they needed earlier, resulting in a lower 24 hours in‐hospital RBC requirement. There is currently no evidence that PHTRBC has influence on LOS in hospital and LOS in ICU.

4.3. *Adverse events* {#tme12659-sec-0024}
---------------------

There have been few instances of transfusion reactions being reported after PHTRBC. Fortunately, transfusion reactions in the general population are rare, with urticaria occurring in 1% to 3% of patients, febrile non‐haemolytic transfusion reaction and cardiac overload in \<1%, and all other transfusion reactions in \<0.1%.[83](#tme12659-bib-0083){ref-type="ref"}

4.4. *Strength and limitations* {#tme12659-sec-0025}
-------------------------------

We performed a thorough search with broad inclusion criteria. The eligibility of studies was assessed independently by two authors. It is therefore unlikely that we have overlooked data that would significantly alter our conclusions. Additionally, despite a different patient population, mechanism of injury and medical facilities, we did not exclude military services but decided to report on them separately, thereby including an important source of data on PHTRBC.

No controlled trials were identified, most observational studies were retrospective, and high heterogeneity also precluded meaningful data pooling. While this at first glance seems a limitation of this systematic review, it is rather a limitation of previous research and in fact an important outcome of this study; this finding highlights the lack of high‐quality outcome studies, and suggests that randomised trials are needed for more conclusive evidence on the causal relationship between PHTRBC and patient outcomes.

5. CONCLUSION {#tme12659-sec-0026}
=============

This systematic review revealed that despite increasing use of PHTRBC by civilian EMS, high‐quality evidence for beneficial effects is still lacking. In the absence of high‐quality data, it seems reasonable to assume that massively bleeding patients may benefit from PHTRBC. This assumption is supported by several observational studies that do suggest possible beneficial effects on mortality. This may especially be true when PHTRBC is combined with plasma administration. PHTRBC also appears to improve haemodynamic parameters, but there is no evidence that shock on arrival to hospital is averted, nor of an association with TIC or LOS in either hospitals or ICUs. Few adverse events have been reported. Given that prevention is generally better than treatment, prevention of haemorrhagic shock through compression of external bleeding, stabilisation of pelvic fractures, prevention of hypothermia and the administration of tranexamic acid should still remain a priority in trauma patients, even when PHTRBC is available.
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